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ABSTRACT 
Introduction and aim 
Despite the wide variation in the target recall rates recommended across different breast 
screening programs, how such variations affect the performance of breast radiologists and 
their decisions to recall when detecting breast cancer are not well understood. Although 
having a high recall rate may increase the probability of cancer being detected earlier, a 
high recall rate also has been related to increased false positive decisions, causing 
significant psychological and economical costs for both screened women and the 
mammography screening service. Such negative effects may hamper the success of 
mammographic screening. Therefore, the purpose of this thesis is to explore the impact of 
various recall rates on breast radiologists‟ performance in a laboratory setting, which may 
lead to a potential improvement in the efficacy of breast cancer screening programs. 
Methods  
Institutional ethics approval was granted. This study was designed to encompass two 
aspects. The first aspect investigated the effect of setting varying recall rates on the 
performance of breast radiologists in screening mammography. The second aspect 
iv 
examined which types of mammographic appearances of breast cancer are more likely to 
be missed when breast radiologists read at different recall rates. To achieve these two 
aspects, five Australian breast radiologists were recruited to read one single test set of 200 
de-identified mammographic cases, containing 180 normal and 20 abnormal cases, over 
three different recall rate conditions: free recall, 15% and 10%. These breast radiologists 
were tasked with marking the location of suspicious lesions and providing a confidence 
rating and they could not exceed the recall rate prescribed, as described in detail in the 
Methods chapter in this thesis. Breast radiologists‟ performance was analysed by receiver-
operating characteristic area under the curve (ROC AUC), Jackknife Free-Response 
Receiver Operating Characteristic (JAFROC) Figure of Merit (FOM), sensitivity, case 
sensitivity, lesion sensitivity and specificity.  All performance data were analysed using 
JAFROC Version 4.2 software and statistical analysis was performed using SPSS software 
version 22.0.  
Results 
Reading at a lower recall rate had a significant positive effect on specificity (H=12.704, 
P=0.002). However, a significant decrease in breast radiologists‟ performance was 
observed when reading at lower recall rates (15% and 10%), with lower sensitivity 
(H=12.891, P=0.002), case location sensitivity (H=12.512, P=0.002) and ROC AUC 
(H=11.601, P=0.003). No significant changes were evident in lesion location sensitivity 
(H=1.982, P=0.371) and JAFROC FOM (H=1.820, P=0.403). The second study of this 
thesis showed that breast radiologists demonstrated higher sensitivity and receiver 
operating characteristic (ROC) area under the curve (AUC) for stellate masses (NSD) 
(H=5.36, P=0.07 and H=7.35, P=0.03 respectively) and mixed features (H=9.97, P=0.01 
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and H=6.50, P=0.04 respectively) when reading at 15% and 10% recall rates. No 
significant change was observed in sensitivity and ROC AUC on cancer characterized as 
stellate (H=3.43, P=0.18 and H=1.23, P=0.54 respectively) and architectural distortion 
(AD) (H=0.00, P=1.00 and H=2.00, P=0.37 respectively). Across all recall conditions, 
stellate lesions were likely to be recalled (90.0%) while NSDs were likely to be missed 
(45.6%).  
Conclusion 
Albeit a significant improvement in specificity was observed, reducing the number of 
recalled cases to 10% significantly reduced breast radiologists‟ performance in this 
laboratory study. The mammographic appearances of cancers contributed to the breast 
radiologists‟ clinical decision-making at low recall rates. Breast lesions characterized as 
stellate were continuously recalled regardless of any recall conditions, which may be due 
to the high likelihood of stellate lesions being malignant.  On the other hand, cancers with 
subtle malignancy signs and a high likelihood of being benign, such as non-specific density 
(NSD), were most likely to be missed at reduced recall rates.  
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THESIS STRUCTURE 
The thesis is arranged into eight chapters and structured in the following manner (Table 1): 
Table 1 Thesis structure  
Chapter  Description  
1 This chapter provides an overview of the aims addressed by the thesis. 
2 This chapter presents a detailed literature review and provides a summary of 
the findings of studies related to recall rates. This chapter fulfills Objective I. 
3 This chapter describes the details of an extended version of the methodology 
used to perform the experiments in this thesis. 
4 This chapter describes a detailed analysis and results from the experiments.   
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Chapter  Description  
5 This chapter presents the main experiment which investigates the impact of 
different target recall rates on reader performance in a laboratory setting 
when reading screening mammograms. This chapter fulfills Objective II. 
6 This chapter presents the extended analysis of the investigation on the types 
of mammographic appearances of breast cancer that are most likely to be 
missed when breast radiologists read at lower recall rates. This chapter 
fulfills Objective III. 
7 Discussion and conclusion presents a discussion of the work as well as its 
implications, limitations and the potential future direction of this research. 
8 Appendices provide an additional published output from this thesis, 
presentations related to this study and the relevant documents for 
participating breast radiologists used in the studies. 
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CHAPTER 1 
INTRODUCTION
 27 
 
Breast cancer screening mammography  
Mammography has been shown to be an effective screening tool for detection of breast 
cancer. Worldwide, breast cancer is the most frequent cancer among females and is the 
second most common cancer overall. In 2012, there were an estimated 1.67 million new 
diagnoses,  which contributed to one in four of all cancer diagnosis  (1). Breast cancer was 
also the most frequent cancer occurring among women worldwide, which places it as the 
fifth most frequent cause of death (522,000 deaths) from cancer overall (1). In Australia, 
breast cancer is currently the most common cancer among  women (2). Over the last three 
decades, the breast cancer incidence rate has more than doubled, from 5,310 to 13,567 
newly diagnosed cases in this country (2). There was a significant increase in the  cancer 
incidence rate between 1990 and 1995, after the national breast cancer screening program, 
known as BreastScreen Australia, was introduced (3).  
Along with breast cancer being most common cancer among Australian women, the 
percentage of deaths caused by the disease has been decreasing over recent years. Early 
detection through breast screening mammography has been demonstrated to significantly 
improve breast cancer survival (4) and it is reported that in 2015, there was a 90% chance 
of surviving at least five years after diagnosis, particularly for women diagnosed with 
invasive ductal carcinoma and smaller tumour sizes, as compared to 72% between 1982-
1987 for the same diagnosis (2, 3). Along with treatment advances in recent years, 
screening mammography is contributing to the reduction in  breast cancer mortality (4), 
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from 68 deaths per 100,000 women in 1991 to 42 deaths per 100,000 women in the general 
population for those aged 50-69 in 2012 (3). 
Through early screening, mammography is able to detect particular changes and 
early signs of cancer before they have developed to an advanced stage. Finding a cancer at 
early stage might lead to less aggressive treatment for the patient and will improve the 
prognosis of the disease. However, there are some population health drawbacks from a 
screening program, such as overdiagnosis (5), false positive and false negative results (6). 
There are debates around these issues, namely about whether screening programs such as 
BreastScreen Australia (BSA) do more harm than good for the greater screened population 
of women who are healthy and cancer free.  
Adverse effects of mammographic screening  
It is known that some cancers may never progress to become symptomatic or 
clinically relevant and this is termed “overdiagnosis”. In every 1000 women attending 
breast cancer screening throughout  the last 10 years, 5 healthy women will be 
overdiagnosed with breast cancer and will likely undergo unnecessary treatment or further 
imaging (6). It is estimated that overdiagnosis can be has high as 42% in women aged 50-
59 (5), prompting great concern in breast screening programs. Another potential adverse 
effect that may compromise the success of population-based screening mammography 
programs is the false positive recall rate (7, 8).  Women that are recalled for further 
assessment and do not have breast cancer are referred as having a false positive result for 
their screening. It has been estimated that the cumulative risk of a false-positive screening 
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result in women aged 50–69 undergoing 10 biennial screening tests varied from 8% to 
21%(7).  
Although recalling a high number of women for assessment may have the potential 
to increase the probability of cancer being detected, an effective screening mammography 
program must consider achieving an appropriate balance between cancer detection and 
recall rates. This is because a large proportion of screened women being recalled for 
additional investigations contributes to unnecessary assessments, patient anxiety and 
additional financial costs (9). Adverse psychological outcomes resulting from a false 
positive result have been shown to have a negative impact on women attending subsequent 
screening in mammography programs (10-12). 
Unfortunately, it has been difficult to avoid these potential harms, and with a low 
incidence of breast cancers in the screened population, which is only 118 per 100,000 
women (13, 14), it makes screening a complex task for radiologists and other mammogram 
breast readers (15-17). Thus, screening programs usually have a stringent quality assurance 
procedure in place to assure the harms in mammographic screening can be minimized and 
the performance of screening programs can be optimized.  
In Australia, a quality improvement program is in place for BreastScreen Australia 
to ensure the ongoing success of the population screening mammography program, with 
high standards quality service in compliance with the National Accreditation Standards 
(NAS). The use of a series of performance indicators/measures, such as sensitivity, 
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specificity, positive predictive value (PPV) and recall rates facilitates monitoring and 
evaluating the program‟s aims of reducing morbidity and mortality from breast cancer. 
Recall rates in breast screening mammography programs 
Recall rates within a breast cancer screening mammography program refer to the 
proportion of screened women who are recalled for further assessments (diagnostic follow-
up or biopsy procedure). When a radiologist identifies a suspicious finding on a 
mammogram, additional diagnostic follow-up imaging, such as ultrasound, magnetic 
resonance imaging (MRI), digital breast tomosynthesis (DBT) or fine needle biopsy may be 
required to confirm the presence of the cancer, and the patient will be asked to return for 
further assessment. Recall rates for first screenings are more likely to be higher than 
subsequent screenings due to lack of previous or prior mammographic images for 
comparison (3).  
National and regional bodies have recommended a maximum percentage of women 
to be recalled for further assessment as a clinical guideline for radiologists when reporting 
screening mammograms.  According to the National Accreditation Standards (NAS) for 
BreastScreen Australia, the recommended maximum percentage of women recalled for 
their first screen and subsequent screen should be less than 10% and 5% respectively (18). 
The United Kingdom (UK) has similar recall rates recommendation for the first screen as  
Australia, while  the recall rate for the subsequent screenings has been recommended to be 
less than 7% (19). Similarly, the American College of Radiology (ACR) also has 
recommended a target recall rate of less than 10% for women who are attending  their first 
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screening mammogram (20), while recommended recall rates in Europe have suggested 
target recall rates less than 5% for the first screen and 3% for the subsequent screen (21).  
A large variation in recall rates have been reported,  ranging from approximately 
1.4% in the Netherlands to more than 15.1% in the US (22). A rate that is too low may be 
associated with decreased sensitivity and a higher number of cancers being missed. 
Conversely, if the recall rate is too high, it may be associated with increased false positives 
findings (23, 24). A report on the performance of BreastScreen Australia showed an 
upward trend in “recall to assessment results”, with a significant increase between 1996–
2000 and 2001–2005, from 6.9% to 9.2% in the first screening round and from 3.8% to 
4.0% in the subsequent rounds. Despite the “recall for subsequent screening”   remaining 
constant at 4% among screened women in the  Australian population, the proportion of 
women being recalled for further assessment for their first screening through BreastScreen 
Australia has increased to a high of 12% in 2013(3). Of these recalled women, most (91%) 
were found to have false positive results, and only 9% had breast cancer (invasive breast 
cancer and ductal carcinoma in situ (DCIS)).  
The variations in recall rates may also be confounded by other factors, including 
the level of expertise of the readers, population screening demographics, the complexity of 
interpretation of mammography images or the national health policy (25-27). These factors 
are generally beyond the radiologist‟s control. Additionally, the results of recall rates 
reported in previous studies may also be influenced by the screening interval (the time 
interval between screenings), with a significant increase in the likelihood of women being 
recalled as the screening interval  increases (28).  Detailed literature on how these factors 
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affect recall rates results in screening mammography is presented as a published article in 
Chapter 2.  
The relationship between recall rates and sensitivity in screening mammography is 
unclear, as evidenced by past conflicting research (23, 24, 29, 30). A study by Gur et al 
(31) reported a linear relationship between recall rates and the cancer detection rate, with a 
significant correlation (r = 0.76; P = 0.01),  and the study suggested that radiologists may 
find more cancers when they recalled at higher rates (>10%). However, other studies found 
that the number of cancers that can be detected does not increase once the recall rates reach 
approximately 5% (23, 29), and suggested an increase in recall rates greater than 5% only 
resulted in higher false positive outcomes, suggesting lower specificity (32).   
Hence the issue around the large international variation in recalling screened 
women for further assessment on diagnostic accuracy remains unresolved. It is unclear 
why some countries such as the Netherland recommend very low recall rates (currently at 
recall rate less than 2%) but still have similar cancer detection rates as the countries such as 
the United States with higher target recall rates (recall rate more than 15%) (32-34). There 
is very little information on how restricting the percentage of women referred for further 
assessment affects radiologists‟ performance, in terms of both receiver operating 
characteristic (ROC) area under the curve (AUC) and Jacknife free response operating 
characteristic (JAFROC) Figure of Merit (FOM) scores. These questions underscore the 
need for further research to explore the effect of various recall rates on diagnostic accuracy 
and radiologists‟ performance. 
 33 
 
Recall rate and mammographic appearances  
Many factors influence the difficulty of reaching a correct diagnosis for normal and 
abnormal cases, especially the characteristics of cancer lesions. A review of previously 
missed cancers reveals lesions with subtle mammographic signs of malignancy are 
commonly missed in mammographic screening, with cancers that present with 
architectural distortion (AD) being the most challenging malignant feature for readers to 
detect (17).  
Fibroglandular tissues and cancer masses appear as radiopaque on mammograms. 
As mammography produces two dimensional (2D) images which are characterized with 
superimposition and overlapping of breast tissue, the presence of breast cancer lesions in 
high mammographic density can be obscured and difficult to visualize. Previous studies 
have shown that breast cancer detection decreased in women with high mammographic 
density, from 80-90% sensitivity in fatty breasts to 29-75% in dense breasts (35-37). 
Although the sample size used for these studies were relatively large (ranging from 576 to 
329,495), there was some variation in classifying the breast density into BI-RADS 
categories, most likely due to human subjectivity. The qualitative approaches used in BI-
RADS classification may lead to differences in decision-making regarding breast density 
information. There is also an increased likelihood of false positive results for women with 
high mammographic density than for women with low mammographic density (38-40). 
According to US and Australian population breast screening data, a higher proportion of 
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women with high breast density, who were predominantly younger (screened women aged 
40-49), were recalled for further assessment (3, 39, 41).  
However, no study has explored the key features of mammographic images related 
to the type of cancer lesions and breast densities that are more likely to be missed and 
affected when radiologists are reading at various recall rates. Identification of the impact of 
specific mammographic features on diagnostic accuracy would facilitate an understanding 
of the complex issue of the image interpretation process and recall decision making, which 
may in turn explain or shed light on variations in radiologists‟ performance (42).  
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Objectives 
The work presented in this thesis was designed to determine the effect of varying 
prescribed target recall rates on the breast radiologists‟ performance when reading 
mammographic images in a laboratory environment.  
The objectives of this research are as follows: 
i. To thoroughly review published studies concerning recall rates in screening 
mammography. 
ii. To investigate the effect of reduced recall rates on breast radiologists‟ performance 
using receiver operating characteristic (ROC) and Jacknife free response operating 
characteristic (JAFROC) analysis.  
iii. To determine whether specific types of mammographic appearances are more likely 
to be missed than others when breast radiologists are operating at different recall 
rates.
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CHAPTER 2 
Reader variability in recall rates have important clinical and economic implications, such 
as unnecessary follow-up procedures, additional costs to the health care system and 
psychological effects for the women themselves associated with false-positive 
mammogram results. However how varying recall rates affect a reader‟s performance 
when recalling women for further assessment in the screening service is not well 
understood.  
The purpose of Chapter 2 (literature review) in this thesis is to provide the reader 
with a detailed understanding of the multifactorial nature that may affect recall rates in 
mammography through a conceptual map of the current literature. This conceptual map 
provides a holistic understanding of recall rates for the health care practitioner in general, 
and for the breast radiologists in particular, of their decision making processes surrounding 
recalling women in a screening service. Chapter 2 is a published journal paper titled 
“Understanding recall rates in screening mammography: A conceptual framework of the 
literature”, which appeared in the journal Radiography – Special Edition in Breast Imaging 
(2015). 
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 UNDERSTANDING RECALL RATES IN SCREENING 
MAMMOGRAPHY: A CONCEPTUAL FRAMEWORK REVIEW OF 
THE LITERATURE 
Chapter 2 is published as: 
N. Mohd Norsuddin, C. Mello-Thoms, W. Reed, S. Lewis. “Understanding recall rates in 
screening mammography: A conceptual framework review of the literature”. Radiography 
– Special Edition in Breast Imaging (2015); 21(4): pp: 334-41. doi: 
10.1016/j.radi.2015.06.003 
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CHAPTER 3 
EXTENDED METHODS 
This chapter is an extended version of method that performed in the experiment work for 
the studies presented in this thesis. The work presented in this chapter provides a detailed 
explanation of the process involved pertaining to the research work for this thesis. The 
methodological approach of this work aided in minimizing the potential cofounders and 
biases that existed in actual screening reading. The work in this chapter was incorporated 
into four main phases; test set development, workstation set-up, reading sessions and data 
analysis.  
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Ethical Approval 
Ethics approval was obtained from University of Sydney Human Ethics Research 
Committee for this study (Project number 2014/484).  Documents related to the ethics of 
this study can be found in the appendix (Appendices A, B, C).  
Participants 
In acknowledging there are other screen readers who provide breast screening 
interpretation including radiologists, breast physicians, mammographers and breast 
practitioners, the participants in this thesis are Australian and the study is contextualized to 
be in the Australian healthcare setting.  Almost 95% of the mammographic interpretation 
in Australia is provided by radiologists and a very small amount of the mammograms are 
read by breast physicians. Radiographers do not report on mammograms in Australia and 
there is no legislative pathway for them to do so. They are not recognized readers of 
medical images by the Commonwealth Department of Health. Therefore, the term used to 
describe readers of screening mammograms in this thesis is breast radiologists. 
All participants in this study are board-certified breast radiologists with 9 to 26 years 
of experience in interpreting screening mammograms and a median of 8,000 
mammographic readings per year. Table 1 details the demographics of the participating 
breast radiologists. This study was conducted at the Medical Imaging Optimisation and 
Perception Group (MIOPeG) laboratory at the Brain and Mind Centre (BMC) of the 
University of Sydney and all participants took part voluntarily.  
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All participants were recruited from BreastScreen New South Wales (BSNSW). An 
invitation to participate in this study was sent to all radiologists who reported 
mammograms for BSNSW. The potential participants were contacted and provided with a 
Participant Information Sheet (Appendix B) in order to obtain more information about the 
study. A mutually suitable time for them to attend the BMC to interpret the cases at three 
separate times was determined. Prior to each reading session, a brief explanation and 
demonstration was given to the participants on how to read images using the customised 
recording software. A consent form (Appendix C) was signed before data collection took 
place. As an expression of gratitude for participation in this study, all participating breast 
radiologists were given a small gift voucher worth 100 AUD. 
Table 1 Demographic details of participating breast radiologists  
Reader 
number 
Number of years of 
experience 
Number of 
mammography cases 
read per year 
Number of hours 
per week reading 
mammograms 
1 15 30 000 10 
2 26 10 000 3 
3 15 10 000 10 
4 9 6 000 24 
5 20 3 500 6 
Median 15 8 000 10 
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Research design  
This study was a laboratory-based experiment. The initial stage of this study involved 
preparing the laboratory environment for the participants which incorporated three 
steps/phases;   
i. Workstation set-up 
ii. Monitor calibration 
iii. Test set development 
Workstation set-up 
The laboratory reading environment and reading procedure were designed to be as 
authentic as possible to the clinical environment in BreastScreen NSW. The images in the 
test set were displayed on a pair of EIZO Radioforce GS510 medical-grade monitors 
(Ishikawa, Japan) driven by a Sectra (Linkonping, Sweden) workstation which is a web-
based picture archiving and communication system (PACS). Two general monitors (Dell 
Inc, United States) were used; A) one for displaying the work list of mammographic 
images in the Sectra system and B) the other displaying the customised recording software 
interface (Figure 1). The workstation was placed in a room with no natural light and the 
surrounding wall painted with a light grey matte colour, to minimize specular reflection. 
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Figure 1 Workstation setup for participants in MIOPeG laboratory. 
Monitor calibration 
Prior to each reading session, the monitors were calibrated to conform to the Digital 
Imaging and Communication in Medicine (DICOM) Gray-scale Display Function (GSDF) 
part 14 standard (1). The purpose of the calibration was to ensure the medical image 
display used in this study was operating at consistent acceptable levels. 
Firstly, the reading monitors were positioned away from direct light sources to 
minimize reflection. Next, each monitor was warmed-up for at least 30 minutes to stabilize 
the monitor output before any measurements were taken. Both monitors were calibrated 
using Verilum software (IMAGE Smiths Inc., Germantown, Maryland, US), whilst 
Monitor A 
Monitor B 
EIZO GS510 monitors 
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monitor performance was assessed according to the American Association of Physics in 
Medicine (AAPM) Task Group 18 Quality Control (TG18-QC) guidelines (2).  
 
Figure 2 The TG18-QC comprehensive test pattern used in the study. 
 
The calibration of the monitors was performed using VeriLUM® 5.2 software 
(IMAGE Smiths Inc., USA). It incorporates a sensor that measures the minimum 
luminance and maximum luminance of the monitors at the centre of the display screen for 
30-50 seconds as in Figure 3. 
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Figure 3 Measuring minimum luminance and maximum luminance of the monitors at the 
centre of the display screen. 
 
The calibrated results of both reading monitors are presented in Table 2. Monitor 1 
and monitor 2 demonstrated the maximum luminance of 421cd/m
2 
and 433cd/m
2 
respectively and the same minimum luminance of 0.88 cd/m
2
. The contrast ratio for 
monitor 1 was 488:1 slightly lower than monitor 2 with a contrast ratio of 492:1. These 
results were in the tolerance levels recommended by the AAPM (2). 
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Table 2 Calibrated monitor results 
Luminance parameter Monitor 1 Monitor 2 
Maximum luminance (cd/m
2
) 421 433 
Minimum luminance (cd/m
2
) 0.88 0.88 
Contrast ratio 488: 1 492: 1 
 
The luminance of monitor was measured using a spectrometer CS-2000 (Konica 
Minolta, Japan) (Figure 4). This telescopic-type luminance meter was placed 50cm from a 
display screen. Measurements were made with a viewing angle of 0.2
0
 in the absence and 
presence (10-18 lux) of ambient lighting. This enabled calculation of the contrast ratio and 
luminance ratio. 
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Figure 4 Konica Minolta Spectroradiometer CS-2000 (Japan) 
The spectrometer was positioned towards the display faceplate at a distance of 50 cm. For 
each of the reporting monitors, all measurements were taken three times. Mean values for 
all parameters were calculated. The monitors demonstrated the output shown in Table 3. 
i. Maximum luminance (Lmax): This refers to the maximum amount of light emitted 
from the monitor. Luminance was measured at the center of the highest luminance 
patch of the TG18- LN test patterns. The SI unit is candela per meter square 
(cd/m2) or foot lambert (FL). 
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ii. Minimum luminance (Lmin): This refers to the minimum amount of light emitted 
from the display. It was measured at the center of TG18-LN01. The SI unit is 
candela per meter square (cd/m2) or foot lambert (FL). 
iii. Contrast ratio: This is the ratio of maximum to minimum luminance in the absence 
of ambient lighting (Lmax/Lmin).  
iv. Just Noticeable Difference (JND): JND refers to change in luminance outputted by 
the system that can be perceived by the human visual system as change in shades of 
grey using an inbuilt look-up-table (2). 
v. Maximum luminance difference between two primary monitors: the percentages 
differences between the maximum luminance of the two primary reporting 
monitors at each workstation. 
vi. Luminance non-uniformity: The maximum deviation of luminance across a monitor 
displaying a uniform pattern (2). This was measured using a TG18-UNL10 test 
pattern. Measurement of luminance was performed at the four corners and center of 
the test pattern, and the percentage deviation was calculated as shown below: 
 
 
 
Percentage difference, Ldev    =       Lmax (2) - Lmax (1)         
                   The higher Lmax (2 or 1)  
                                            
x 100% 
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Table 3 Output results of reporting monitors 
Luminance 
parameter 
AAPM Guidelines for 
primary displays  
Monitor 1 Monitor 2 
Maximum luminance, 
Lmax (cd/m
2
) 
≥ 170 
≥ 450  
413 416 
Minimum luminance, 
Lmin (cd/m
2
) 
≤ 1.5 0.92 0.93 
Contrast ratio (CR) ≥ 250 
≥ 300 
449: 1 447:1 
Just Noticeable 
Difference (JND) 
NA 609 609 
Percentage difference ≤ 5% 
≤ 10% 
0.7% 0.7% 
Luminance non-
uniformity 
(Percentage 
uniformity) 
≤ 30% 8.5% 8.2% 
 
Ambient lighting measurement 
The ambient lighting of workstation was measured using a chroma meter (Konica Minolta, 
Japan) at a distance of 70 cm from the display screen. The measurement was performed 
under two different monitor conditions; either turned off or on. Only ambient light 
reflections were measured when the monitor displays were turned off, whilst another 
measurement was taken when the monitor was displaying the mammographic images. 
Ambient lighting levels were kept between 10-20 lux throughout the study.  
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Customised recording software 
A customised software program was developed for this study. The software allows 
the reader to identify and mark the location of any cancers found in the test set without 
writing responses on paper, or dictating a decision, as is generally done in clinical practice. 
The software also provides direct feedback to the reader about the number of cases recalled 
in each round of the study and allows them to alter the number according to any prescribed 
recall rate.  
This customised recording software was developed in the Java programming 
environment (Java version 1.7) by a computer programmer. All images used in this 
software were extracted from the test set stored on a university SECTRA workstation and 
were resized to the desirable monitor size (53cm x 30cm). Each mammographic case 
consisted of 2 views of both breasts (craniocaudal (CC) and mediolateral oblique (MLO). 
These images were then stitched together to form a combined image as shown in Figure 5. 
This software was designed to run on any computer or system with 256 MB RAM and Java 
virtual machine support capabilities. This dedicated customised recording software only 
supported standard image formats such as JPEG, PNG, GIF, JPG, TIF but not DICOM. 
The database files were continuously stored on a H2 database from where the software was 
started (the current working directory). As well as facilitating the lesion location selected 
by the reader, the software also captured the data of lesion coordinates allowing statistical 
analysis using a Jackknife free response operating characteristic (JAFROC) method (3). 
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Figure 5 Digital mammography display for user interface in customised recording 
software 
The response to each case was registered via a mouse event. When the reader 
identified a suspicious lesion on the image, he/she must first decide whether the case is 
warranted for recall or not, as defined by BreastScreen Australia‟s classification system 
(Table 6). Once the recall decision was made, the reader was required to mark the location 
and give a confidence score using the “mark lesion” button. A square lesion box with drop-
down list of confidence score ranging from 1 to 5 popped up adjacent to the images 
(Figure 6). The lesion box was able to be moved and resized to the respective lesion 
location and size. If the case did not warrant recall for further assessment and was deemed 
normal, the reader could move to the next case by clicking the “next” button and a score of 
1 was automatically assigned to the case. A score of 2 was given if a benign lesion was 
thought to be present. Readers could also review and change their decisions before the 
reading session ended.  
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Figure 6 Snapshot of the lesion box and confidence score displays on left medio-lateral 
oblique (MLO) view.  
The customised software was not integrated with the Sectra workstation but rather 
the reader recorded their interpretation and located any lesions on a laptop that displayed 
identical images in the same order as those displayed on the reporting monitors. 
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Application set-up 
The following steps guide how to run the software and start the application server:  
1. Find file known as launch.bat in SOFTWARE folder. 
2. Double click the launch.bat file.  
3. Wait until a black window known as shell (Figure 7) is loaded. This shell must 
be run before any reading session takes place.  
 
 
Figure 7 Snapshot of a black window (shell) 
 
 
 
 66 
 
4. Open the internet browser. 
5. Type the following address or Uniform Resource Locator (URL) into the 
address bar: http://localhost:8080/assess/<ReaderiD>Readingsession (e.g 
http://localhost:8080/assess/1/1) 
The above URL was linked to the test set prepared for reader number 1 for his/her first 
reading session. A different reader was assigned with specific reader number for each 
reading session. 
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Test set development  
One identical test set of images was used throughout this study and comprised of two 
hundred mammographic cases which were obtained from the BreastScreen NSW digital 
imaging library. Permission to use the images was granted from BreastScreen NSW. All 
patients‟ identification details were removed from the images. The selection of the 
mammographic cases used in test set was gathered by a radiographer with more than three 
years of experience in mammography and validated for inclusion by the NSW State breast 
radiologists. The number of abnormal cases used in the set was designed to simulate 
Australian recall rate for the first screen (10%). All mammographic cases used in the test 
set were generated between January 2006 and October 2011, and previously read and 
reported by two or three radiologists during routine screening.  
The test set contained 20 abnormal and 180 normal cases, with the abnormal cases 
having a single biopsy-proved malignancy. All normal cases in the test set were 
determined by a report finding of normal/return to screen produced at the 2 years follow up 
assessment. That is, both mammograms were taken 2 years apart and both reported as 
normal by two independent blinded breast readers. Each mammographic examination 
consisted of two-view digital mammograms (cranio-caudal view (CC) and medio-lateral 
oblique (MLO) of both breasts) with a range of lesion difficulties, from subtle to obvious 
cancer presentations which were determined by the percentage of readers detecting 
individual lesions. The 20 abnormal cases had various types of abnormal mammographic 
appearances (stellate mass, non-specific density (NSD), architectural distortion (AD) and 
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mixed appearance of calcification and AD, and stellate and NSD), with 16 cases the cancer 
was visible on both mammographic views (CC and MLO) of a given breast, while four 
cases had a visible lesion on either one of the mammographic views, which resulted in a 
total of 36 malignant lesions available for localization. The distribution of lesion 
characteristics was chosen by clinical audit and it represents the distribution of lesions that 
are commonly missed in clinical practice in Australia consecutive audit within 
BreastScreen and are therefore representative of the normal, benign and malignant cancer 
cases within the screened community.  The variation in lesion types was representative of 
the natural variation and there was no intent to alter the prevalence of a specific cancer 
type to have it included in the study. 
All images passed the BreastScreen Australia (BSA) quality assessment, and 5% of 
the 200 cases were digitized film-screen and 95% full field digital mammography (FFDM). 
As the test set was designed to represent actual clinical prevalence, only images that 
fulfilled image criteria (positive and negative cases) were consecutively chosen to be 
included in the test set until the predetermined number of abnormal and normal was 
reached. No other specific criteria were used in the selection of cases. For the purpose of 
simulating the first screening read, no prior images were provided to the readers.  
Justification for 200 mammographic cases 
The 20 breast cancer cases in the test set were randomly mixed with 180 normal cases in a 
1:10 ratio. These 200 mammographic cases formed an appropriate sample size to create the 
test set for this study determined and confirmed by sample size tables for receiver 
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operating characteristics studies modelled by Obuchowski, NA (4). To evaluate the 
adequacy of sample size used for this study, the following measurements were considered.  
i. The average of ROC AUC of  0.80 (high accuracy) 
ii. Large observer variability (interobserver =0.05, interobserver=0.01) 
iii. Large relative frequency of normal and abnormal cases in the study, R 
(value of R=4/1) 
For the sensitivity at a false-positive rate less than or equal to 0.10, the estimated number 
of cases needed for four observers the test set was 50. However, for the purpose of 
resembling the clinical prevalence of breast cancer, the test set was enriched with an 
elevated number of mammographic cases. The case number of 200 was also chosen to 
allow a test set that did not overload the readers to finish the task in one sitting.  
Truth (Gold standard) 
The specific location of the cancer site and malignancies in the 20 abnormal cases were 
then identified by one expert breast radiologists who is involved in training assessment, 
quality, clinical policies of BreastScreen NSW and also is responsible for the clinical 
management of a screening centre. To assist the expert to determine the location and the 
particular mammographic appearance of the depicted abnormalities, this expert had access 
to the biopsy reports and the prior images if available. These locations were defined as the 
truth and were used in analysing the cases marked by the readers.  
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Mammographic appearances of cancers in the test set: detailed classification  
The cancer cases and lesions examined in this work presented with varying mammographic 
appearances. All malignancies present in the 20 cancer cases were characterized by the 
expert breast radiologists according to the lesion type, breast density and location of lesion 
with respect to the fibroglandular tissue and these details are provided in Table 5. These 
characteristics were based on Australian Synoptic Breast Imaging Report of the National 
Breast Cancer Centre (NBCC) (5) as described in Table 4, to assist with understanding the 
terms of lesion abnormalities used in this thesis.  
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Table 4 Definition of lesion abnormalities according to Australian Synoptic Breast 
Imaging Report 
Lesion abnormalities  Definition  
Calcification Deposition or collections of calcium compounds in 
breast tissue of sufficient size to be seen on 
mammogram and malignancy are characterised by size 
(0.05-0.5mm), calcification distribution (cluster, 
multiple cluster, or sometimes scattered), 
pleomorphism and variation of density.  
Stellate lesion Spiculations of variable length radiating from a central 
point or mass. If a central mass is present, it may be 
small or large, and of low, mixed or high density 
compared to surrounding breast parenchyma. 
Architectural distortion 
(AD) 
Abnormal configuration of the ductal and ligamentous 
structures of breast parenchyma compared with the 
remainder of the breast tissue markings and often 
appears with spiculation, focal retraction, distortion of 
the parenchymal edge, and disorganisation of 
markings. 
Non-specific density 
(NSD) 
Asymmetry of breast tissue seen in one of the breast, 
on either one or two mammographic views with poorly 
defined characteristics of breast density.  
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There were four different mammographic appearance types of cancer presented in 
this test set; 8 cases had stellate lesion; 6, non-specific density (NSD); 2, architectural 
distortion (AD); 3, mixed appearance of calcification and AD; and 1, mixed appearance of 
stellate and NSD. For breast density, 2 cases had entirely fat (<25% glandular tissue); 7, 
scattered fibroglandular densities (25-50% glandular tissue); 8, heterogenerously dense 
(51-75% glandular tissue); and 3, extremely dense appearances (>75% glandular tissue). 
Figure 8 shows the example of mammographic cases with four specific breast density. In 
the test set in this study, 55% of the cancer cases had heterogeneously and extremely dense 
breast, 10% had entirely fat and 30% had scattered fibroglandular densities. This 
distribution of breast cancer in this study is similar to the breast density population that 
commonly found in women aged 40 to 75 worldwide (6-8).  
 73 
 
 
Figure 8 Example of mammographic images with different breast density A) < 25% 
glandular tissue, B) 25-50% glandular tissue, C) 51-75% glandular tissue, D) >75% 
glandular tissue 
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In term of lesion location, lesions in 11 cases were overlapped the fibroglandular tissue; 
lesions in 6 cases being outside the fibroglandular tissue and lesions in 3 cases at the edge 
of the fibroglandular tissue (Figure 9).  
 
 
Figure 9 Mammographic images above showed lesion (circled) location to 
fibroglandular tissue A) overlapping fibroglandular tissue, B) outside fibroglandular 
tissue and C) at the edge of fibroglandular tissue   
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Table 5 Mammographic appearances of 20 cancer cases present in the test set 
Case ID  Type of lesion Breast density  Lesion location  
MJBJ AD  25-50% glandular tissue Overlay fibroglandular tissue 
MJAS Calcification + 
AD 
>75% glandular tissue Overlay fibroglandular tissue 
MJBG Calcification + 
AD 
51-75% glandular tissue Overlay fibroglandular tissue 
MJBK NSD 51-75% glandular tissue Overlay fibroglandular tissue 
MJBL Stellate >75% glandular tissue Overlay fibroglandular tissue 
MJCF NSD >75% glandular tissue Overlay fibroglandular tissue 
MJCQ NSD 51-75% glandular tissue The edge of fibroglandular tissue 
MJCR Stellate 25-50% glandular tissue Outside fibroglandular dense 
tissue 
MJCX Stellate < 25% glandular tissue Outside fibroglandular dense 
tissue 
MJDA Stellate 51-75% glandular tissue Outside fibroglandular dense 
tissue 
MJDH Stellate 51-75% glandular tissue Outside fibroglandular dense 
tissue 
MJDU Stellate 51-75% glandular tissue Overlay fibroglandular tissue 
MJEA Stellate 25-50% glandular tissue Overlay fibroglandular tissue 
MJEB NSD 25-50% glandular tissue Outside fibroglandular dense 
tissue 
MJEG Calcification + 
AD 
25-50% glandular tissue Overlay fibroglandular tissue 
MJGR Stellate 25-50% glandular tissue Overlay fibroglandular tissue 
MJHD AD < 25% glandular tissue Outside fibroglandular dense 
tissue 
MJHH NSD 51-75% glandular tissue Overlay fibroglandular tissue 
MJHJ NSD 25-50% glandular tissue The edge of fibroglandular tissue 
MJHK Stellate 51-75% glandular tissue The edge of fibroglandular tissue 
    
*AD, architectural distortion 
ⱡNSD, non-specific density 
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Mammograms randomization 
In order to eliminate any possible reading order biases that may arise in this experiment, 
the order of cases in the test set was randomized in a different order for each reader and for 
each reading session. The Sectra and customised recoding lists were synchronised post 
randomisation.   
Prior to the randomization, a free online random number generator, 
RANDOM.ORG that is available at https://www.random.org was used to randomise the 
sequence of cases in the test set and a pre-randomized list was prepared for this study 
process. This list was used as a reference in randomizing mammographic cases in the 
SECTRA workstation and in the customised recording software.  
Randomizing cases in Sectra system  
The 200 mammographic cases in the Sectra system were then randomized with reference 
to the pre-randomised list prepared earlier. A test set with the new randomized sequence 
was de-identified from the patients‟ information and provided with a new unique ID. This 
new unique ID was created in the Sectra by adding a number in front of the existing case 
ID, for example, if the existing case ID: MJAA, new case ID is 003 MJAA.  
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Randomizing cases in customised recording software 
The customised recording software designed for this study was independent software 
which was not integrated with the Sectra system. A separate case worklist was created to 
ensure the displayed cases on the customised recording software matched with the cases 
displayed on the reporting monitors of the Sectra system. For each reader, the sequence in 
the customised recording software was the same as the one created in the Sectra system. 
Image presentation (display protocol) 
Once these 200 mammographic images were randomly sorted, images were displayed in 
the following order as it would be viewed in BreastScreen clinic (Figure 10) and readers 
could alter the image order backwards and forwards. 
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Figure 10 Image display sequence for reading process
i. 
 
 
2 MLOs and 2 CCs 
ii. 
 
 
RMLO and LMLO 
iii. 
 
 
RCC and LCC 
iv. 
 
 
RMLO and RCC 
v. 
 
 
LMLO and LCC 
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Reading task 
All participants read the same 200 cases at three reading sessions. At first reading session, 
the readers were allowed to recall as many cases as they believed necessary. For the second 
and third reading sessions, readers were given a prescribed recall rate at the beginning of 
the session and required to interpret each mammographic case. The readers were briefed 
how to review and rate the test set, followed by a demonstration on how to use the 
customized recording and Sectra software. No information was provided on the number of 
cases with abnormal findings or the number of lesions on the images.  
During the reading sessions, the participants were required to identify each 
mammographic case that they considered recalling in keeping with their free or specified 
target recall rate. The readers were asked to mark the location of the suspicious lesions 
within the recalled cases using customised recording software and provide a confidence 
rating ranging from 1 to 5 for the location of detectable lesions of each recalled cases      
(1: definitely normal, 2: probably benign, 3: uncertain, 4: probably malignant, 5: definitely 
malignant). No time limit was set for the reporting session. 
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Figure 11 Reading process flow for readers when performing the reading task 
Yes 
No Normal case  
(Automatically will be 
assigned a score of 1) 
 
No 
Benign case  
(Will be assigned a 
score of 2) 
 
TASK 
Identify to be 
recalled for 
further 
assessment  
SAMPLE 
 Breast Readers 
Locate the suspicious lesion using 
customised recording software 
Move to the next case 
Provide the confidence score 
3 5 Confidence of malignancy 
Identify cases that 
need to be recalled for 
further assessment 
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Reading conditions 
This longitudinal study was divided into three reading sessions. Each session had a 
different recall rate condition and was separated by a minimum of two months to reduce 
any memory effects and learning bias. The total study time was six months for the three 
reads for each reader.  
At the first reading session, no numerical percentage recall rate was imposed and 
termed “free recall” when interpreting the cases. At this condition, the reader could recall 
as many cases as necessary.  For the subsequent readings (second and third session), the 
number of mammographic cases that readers could recall was then constrained to a certain 
number/percentage. Readers were restricted to recall a maximum of 30 cases (15%) in their 
second reading and 20 cases (10%) in the third reading. The determination of the 
percentage of the recalled cases for second reading session of 15% was based on 
international results of recall rates, in which the highest recall rate was 15.1%, as applied in 
the USA (9). For the third session, the percentage of 10% was determined to align with the 
first screening recall of BreastScreen Australia and proportion of abnormal cases in the test 
set was made to comply with the Australian standard (10). 
Breast Screen Australian classification system 
This confidence scoring system used in this work was aligned to BreastScreen Australia 
(4) practice for classifying mammographic lesions. Table 6 shows the details of the 
numerical score for respective recall decisions made by each reader during the reading 
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session. A score of 1 and 2 would be considered to a normal and benign decision 
respectively, and a score of 3, 4 or 5 would be equated to a recommendation of a 
suspicious case which is recalled for further assessment. The readers were not required to 
classify the types of lesions for each recalled case.  
Table 6 Recall recommendation based on Australian Classification System 
Category Description  based on the 
Australian Classification System 
Recall Recommendation  
1 No significant imaging abnormality 
 
Normal : No recall to 
assessment 2 Benign findings and no further 
imaging is required  
Threshold of recall 
3 Intermediate/equivocal findings and 
further investigation is required  
 
4 Suspicious findings of malignancy 
and further investigation is required 
Suspicious malignant - 
recall to assessment  
5 Malignant findings and further 
investigation is required 
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Data Analysis 
Data from this experimental work were analysed in two phases as shown in Figure 12; the 
first phase of analysis began by evaluating the overall performance of the readers when 
reading the screening mammograms at three varying levels of recall rates.  
The initial part of this work in assessing reader performance was investigating three 
performance metrics; sensitivity, specificity and receiver operating characteristic (ROC) 
area under the curve (AUC). Further analysis was then performed in later work to explore 
the effect of reduced recall rates on readers‟ performance through a methodology that 
incorporates the lesion location information. Through this methodology, the readers‟ 
ability to correctly locate lesions and give a confidence rating based on these decisions was 
assessed. With the addition of the number of participating readers, the performance of 
readers to correctly locate lesion was analysed through case location sensitivity, lesion 
location sensitivity, and Jack-knife free-response ROC (JAFROC) figure of merit (FOM).  
The second phase of the analysis focused on exploring mammographic lesion 
appearances. The analysis was performed by identifying the cancer appearances that were 
more likely to be missed when readers performed at lower recall rates.  
Chapter 5 in this thesis explains and discusses thoroughly the first part of this 
analysis work, whilst Chapter 6 reports the results of subsequent analysis. 
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Figure 12 Schematic overview of the steps involved in the analysis process 
Mammographic appearances of missed cancers 
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Recall rate to assessment 
The rate of recall to assessment at the first reading session (free recall condition) for each 
reader was defined as the proportion of recalled cases that reader considered needed further 
assessment. It was calculated by the follow equation:  
 
 
Performance metrics  
Overall, for all reading sessions, reader performance was assessed using sensitivity, 
specificity, case location sensitivity, lesion location sensitivity, receiver operating 
characteristic (ROC) area under the curve (AUC) and Jack-knife free-response ROC 
(JAFROC) figure of merit (FOM). Details of each performance metric used for this study 
are further explained in Chapter 5.  
ROC analysis  
Receiver operating characteristic (ROC) analysis is a binary paradigm focused on a single 
rating per case that is commonly used in assessing the accuracy of a radiologist‟s 
interpretation of mammography images. The evaluation of a reader‟s accuracy is based on 
the reciprocal relationship of sensitivity (true positive fraction (TPF)) and specificity (false 
positive fraction (FPF)) at various test positive thresholds which are graphically presented 
Recall rate :  
Total number of recalled cases 
Total mammographic cases in the test 
x 100% 
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as an ROC curve. The area under the ROC curve (AUC) was used as a figure-of-merit to 
represent the overall performance index between 0.0 to 1.0, with 0.0 indicating the worst 
test and 1.0 being the perfect accuracy test. An ROC AUC of 0.5 corresponds to a random 
guess, giving a completely uninformative test.  
In this study, the reader was given a task to interpret a set of mammography 
images/cases where the radiologist needed to rate their confidence in the presence or 
absence of cancers for each case where the reader was allowed to give only one rating for 
each case (positive or negative). Analysis using this binary approach disregarded the 
number of cancer lesions present or their precise location.  
JAFROC analysis 
JAFROC analysis is an advanced quantitative analysis of reader performance when 
interpreting mammography images. This analysis incorporates a free-response paradigm 
that allows lesion location information to be included when analysing reader performance. 
In this study, a TP score was given to a lesion when a reader successfully marked and 
localized the lesion correctly within the acceptance radius. Furthermore, with the 
additional information of lesion location, this method demonstrates higher statistical power 
as compared to the ROC analysis (11). Through this method of analysis, the readers were 
allowed to locate multiple suspicious lesion locations during the interpretation process. The 
non-parametric area under the alternative free-response receiver operating characteristic 
(AFROC) curve was used as the figure of merit for JAFROC and the graph was plotted as 
 87 
 
the lesion localisation fraction (LLF) versus false positive fraction (FPF). An acceptance 
radius surrounding each lesion was used as a proximity criterion in determining whether 
the lesion was correctly marked or not.  
For this study, a 60-pixel acceptance radius surrounding each lesion (within 20 
millimeters) was defined to classify each mark. This acceptance radius was chosen as it 
encompassed the largest malignant lesion present in the test set. The marked lesions were 
identified either as positive or negative by comparing selections with the truth table 
compiled by the expert breast radiologist. A true positive (TP) was scored if a lesion was 
marked within the acceptance radius and received a confidence score between 3 and 5. A 
false positive (FP) was defined for any incorrect localization on normal cases, or if the 
localisation was outside the 60 pixels range of a lesion in abnormal cases. A lesion that 
was correctly localized but received a confidence score of 2 was considered as a false 
positive lesion. A true negative (TN) outcome was recorded if the case was correctly 
identified as normal or lesion-free. A false negative was scored when cancer lesions were 
not marked.  
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Data extraction 
All data stored in the customised recording software were exported in Microsoft Excel 
(xls) file format by accessing the following URLs. This browser will return a file, an excel 
file, that can be saved on the computer for further analysis. The step-to-step how to extract 
the data from the data from the software is described as below:  
i. To access all case readings: insert the following address or URL into the address 
bar:  http://localhost:8080/export/cases. A specific file named as Assessments.xls 
will be appeared and can be saved on the computer. 
ii. To access the lesion coordinate details: insert the following address or URL into 
the address bar: http://localhost:8080/export/tags. A specific file named as Tags.xls 
will be appeared and can be saved on the computer. 
iii. To access details of user activity (as details of readings that were modified such as 
changed or removed later: insert the following address or URL into the address bar: 
http://localhost:8080/export/audits. A specific file named as Audits.xls will be 
appeared and can be saved on the computer. 
iv. To export the rating score of specific case and reader: insert the following 
address or URL into the address bar: 
http://localhost:8080/assessment/{userId}/{sessionId}/{caseId}. For example: 
http://localhost:8080/assessment/1/1/MJAB; this URL will link to specific case 
identified as MJAB for reader number 1 for his/her first reading session. 
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v. To export the lesion marking of a specific case: insert the following URL into the 
address bar/ browser: http://localhost:8080/tag/{userId}/{caseId}. For example: 
http://localhost:8080/tag/1/1/MJAB. 
Lesion localization 
The extracted data from the customised recording software were compiled in an Excel 
datasheet. The figures in the dataset provide the location of four corners of the lesion box 
in coordinates of X and Y. The coordinates at the centre of the lesion were calculated from 
the available information extracted from the customised recording software. From figures 
given in the dataset, X1 and Y1 were the coordinates of left most top corner of the lesion 
box (A), while X2 and Y2 were the coordinates of the right most bottom of the lesion box 
(C).  
 
 
 
  
 
 
A (X1, Y1) B (X1, Y2) 
C (X2, Y2) D (X2, Y1) 
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The coordinates (X3 and Y3) of the centre of the lesion were therefore calculated using the 
formula below: 
    
The lesion location of 20 abnormal cases from the truth table were calculated and only 
known by the researchers (Table 7). 
 
Centre of the lesion (X3, Y3)   =  {(X2 –X1) / 2 + X1}, {(Y2-Y1) / 2 + Y1} 
       For example; if (X1, Y1)   =  (518, 250), (X2, Y2) = (548, 280); 
The coordinate of (X3, Y3)    =  {(548-518)/2) + 518}, {(280-250)/2 + 250} 
                                                =   (533, 265) 
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Table 7 The truth location of lesion coordinates of abnormal cases 
No. Case ID Lesion coordinates (X, Y) 
1. MJAS (215, 253) 
  (542, 258) 
2. MJBG (122, 370) 
3. MJBJ (123, 244) 
  (451, 297) 
4. MJBK (142, 418) 
  (492, 354) 
5. MJBL (87, 257) 
6. MJCF (486, 380) 
7. MJCQ (208, 316) 
  (539, 303) 
8. MJCR (140, 285) 
  (421, 315) 
9. MJCX (86, 229) 
  (479, 311) 
10. MJDA (118, 289) 
  (549, 323) 
11. MJDH (119, 228) 
  (519, 290) 
12. MJDU (159, 428) 
  (478, 403) 
13. MJEA (216, 175) 
  (508, 208) 
14. MJEB (242, 275) 
  (654, 260) 
15. MJEG (188, 261) 
  (488, 301) 
16. MJGR (183, 252) 
  (629, 242) 
17. MJHD (223, 446) 
  (586, 459) 
18. MJHH (225, 269) 
19. MJHJ (200, 542) 
  (513, 483) 
20. MJHK (238, 375) 
  (551, 411) 
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Comparison recording software output to truth (gold standard) 
The locations of marked lesions were compared with the truth table. The decision made 
during the reading task by each reader was categorised into TP, FP, TN or FN based on the 
detection criteria previously defined. The data were then analysed using JAFROC Version 
4.2 software (3, 11) developed by Dev P. Chakraborty and available at 
www.devchakraborty.com. 
Statistical analysis  
Reader Performance  
To compare readers‟ performance across three recall conditions, individual performance 
results were pooled across the readers and a non-parametric statistical analysis was 
performed using SPSS Software version 22.0. Data in each reading condition was treated 
independently and the statistical analysis was performed in two steps;  
i. Kruskal-Wallis test: this test was performed across the three reading sessions with 
statistical significance set at P < 0.05 at 95% confidence intervals (CIs). If the 
results from the Kruskal-Wallis test shown statistically significance, post-hoc 
analysis was needed to identify which groups were significantly different from each 
other.   
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ii. Mann-Whitney U test: Each recall condition was grouped into three pairs (free 
recall and 15%, 15% and 10%, 10% and free recall) and comparison was made 
using Mann-Whitney U test. Bonferroni adjustment was applied to the alpha values 
by dividing the alpha level by the number of comparisons made (n=3) to control for 
Type 1 error. Results therefore with the revised alpha level, a P < 0.017 were 
deemed to represent significant differences. 
 
Mammographic appearances of missed cancers 
Contrary to analysis of Study 1, analysis of study 2 focused on determining whether the 
detection of any specific cancer types altered when the recall rates were reduced 
(Condition 15% and 10%), which narrowed the analysis to the 20 abnormal cases only. 
The mammographic appearances of the cancer lesions used in this study were classified 
into three categories: 
i. lesion type;  
ii. breast density and  
iii. location of the lesions  
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Localization and identification of mammographic appearances of 20 abnormalities were 
made by the same expert breast radiologist who determined the ground truth of the test set. 
The mammographic appearances were chosen according to the synoptic and standardised 
breast reporting report practice in Australia. This synoptic breast imaging is similar to the 
Breast Imaging Reporting and Data System, BI-RADS criteria, 4
th
 edition, endorsed by the 
Royal Australian and New Zealand College of Radiologists (RANZCR). Breast density 
was categorised into 4 groups:   
1. The breast is almost entirely fat (<25% glandular)  
2. There are scattered fibroglandular densities (25–50% glandular)  
3. The breast is heterogeneously dense (51-75% glandular)  
4. The breast tissue is extremely dense (>75% glandular) 
 
The following chapter, Chapter 4, gives results of performance at the individual level, 
before presenting the results of the group performance via journal manuscripts. Chapter 5 
has recently been submitted to The Breast Journal (TBJ), and is currently under review. 
Chapter 6 has been accepted for publication (in Press) by the British Journal of Radiology 
(BJR) (http://www.birpublications.org/toc/bjr/0/0). 
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CHAPTER 4 
EXTENDED RESULTS 
This chapter serves as bridging section for chapter 5 and 6 and provides some 
complimentary results related to articles 2 and 3. The results presented in this chapter 
assess the readers‟ performance at an individual level. 
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Individual performance within the free recall 
Results of individual recall rates for the breast radiologists ranged from 18.5% to 34.0% 
when reading at the free recall condition as shown in Figure 13. Reader 3 recalled the 
highest number of lesions among the readers, with 34.0%, while Reader 4 had the lowest 
rate (18.5%). With an average of 25.6%, this recall rate yielded a considerably higher rate 
than recommended by BreastScreen Australian for a woman‟s first screen, which is 
currently set at 10% (1).  
 
 
 
 
 
Figure 13 Histogram of individual recall rate of each reader at the free recall condition 
23.0% 
28.0% 
34.0% 
18.5% 
25.0% 
Reader1 Reader2 Reader3 Reader4 Reader5
Recall rates at free recall condition 
Recall rates
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ROC curve 
The individual relationship between sensitivity and the false positive fraction (FPF) is 
illustrated through ROC curves. Figure 14 illustrates the corresponding ROC curves for all 
three recall conditions for each reader. Variability can be seen between readers and also 
within reads. The overall performance of readers in this study was reported by the ROC 
area under the curve (AUC) as presented in Chapter 5. ROC AUC is able to summarize the 
whole ROC graph into a single performance index, whereby it combines the measures of 
sensitivity and specificity. 
AFROC curve  
The Jack-knife free-response ROC (JAFROC) figure of merit (FOM) of individual readers, 
when performing at three different recall conditions is illustrated by the non-parametric 
area under the alternative free-response receiver operating characteristic (AFROC) curve 
as shown in Figure 15. The relationship shown in the curve was defined as the lesion 
localisation fraction (LLF) versus FPF and the overall performance with regards to 
JAFROC FOM is reported in Chapter 5. 
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Figure 14 The empirical ROC curves for each reader when performing at three different recall 
conditions (i. Free recall, ii. 15% recall and iii. 10% recall).   
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a) Reader 1 b) Reader 2 
c) Reader 3 d) Reader 4 
 
e) Reader 5 
 Free recall 
15% recall 
10% recall 
Figure 15 The empirical AFROC curves for each reader when performing at three different recall 
conditions (i. Free recall, ii. 15% recall and iii. 10% recall).  
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Lesion detectability at free recall, 15% and 10% recall rates 
Table 8 shows lesion detectability for each of the cancer cases across all reading sessions 
(S1: free recall, S2: 15% recall and S3: 10% recall) at individual reader level. Cancer cases 
that were correctly identified by readers were assigned as true positive (TP) and were given 
a green colour. For every missed cancer, the case was marked with red colour and assigned 
a false negative (FN).  Readers demonstrated wide differences in the detectability of lesions 
within and between readers. Across the 20 cancer cases, lesion detectability was consistent 
for 6 cancer cases (MJBL, MJCX, MJDA, MJDH, MJEA and MJGR) regardless any recall 
conditions imposed on the readers. The marking of one cancer was found to be very 
difficult by majority of the readers (n=4) at all recall conditions, and only reader 5 was able 
to detect the cancer lesion MJCF at free and 15% recall rates, however this reader then 
missed the lesion at the recall condition of 10%.   
Inconsistency in lesion detectability at the individual level for certain cancer lesions 
was observed when reading at different recall conditions. For example, for Reader 1, the 
ability to recognise two cancer cases (MJAS, MJBJ) and correctly recall these as malignant 
was inconsistent. Those two cases were identified as malignant at the free recall condition, 
however at the 15% recall condition, the cases were reported as normal and hence did not 
warrant any recall for further assessment. Furthermore, later in the experiment, these cases 
were identified as malignant at the 10% condition and hence recalled. This decision pattern 
was also observed in Reader 3 for case MJAS and Reader 5 for case MJBJ. It is interesting 
to note that there were cancer cases that were not reported at the free call and 15% 
conditions but were recalled at the last reading condition (10%), as demonstrated by 
Reader 3 (MJBK). However, Readers 1, 4 and 5 changed their decision on cases from 
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being malignant (15% recall) to normal case at the third read (10% recall) when reading 
case MJEB (Reader 1), MJHK (Reader 4), MJBG and MJHD (Reader 5). The extended 
results from this work are reported in Chapter 6.  
Following the classification of marked or missed lesions across all 3 conditions by 
the 5 readers, the individual reader‟s results were then grouped into three difficulty levels 
(lower, medium and higher difficulty) and the variability in readers‟ recall decision was 
discussed according to the mammographic appearance of the cancer cases in Chapter 6. 
 103 
 
 
Reader 1 Reader 2 Reader 3 Reader 4 Reader 5 
Case ID S1 S2 S3 S1 S2 S3 S1 S2 S3 S1 S2 S3 S1 S2 S3 
MJAS TP FN TP TP FN FN TP FN TP TP TP TP TP FN FN 
MJBG TP FN FN TP FN FN TP FN FN FN FN FN FN TP FN 
MJBJ TP FN TP TP TP TP TP TP TP TP TP FN TP FN TP 
MJBK TP TP FN TP TP FN FN FN TP TP TP TP FN FN FN 
MJBL TP TP TP TP TP TP TP TP TP TP TP TP TP TP TP 
MJCF FN FN FN FN FN FN FN  FN FN FN FN FN TP TP FN 
MJCQ TP TP TP TP TP FN TP TP TP TP TP TP TP TP TP 
MJCR TP TP FN TP FN FN TP TP FN FN FN FN TP TP TP 
MJCX TP TP TP TP TP TP TP TP TP TP TP TP TP TP TP 
MJDA TP TP TP TP TP TP TP TP TP TP TP TP TP TP TP 
MJDH TP TP TP TP TP TP TP TP TP TP TP TP TP TP TP 
MJDU FN FN FN TP TP FN TP TP FN TP TP FN FN FN FN 
MJEA TP TP TP TP TP TP TP TP TP TP TP TP TP TP TP 
MJEB FN TP FN TP FN FN TP FN FN TP FN FN TP FN FN 
MJEG TP TP TP TP TP TP TP TP FN TP FN FN TP TP TP 
MJGR TP TP TP TP TP TP TP TP TP TP TP TP TP TP TP 
MJHD TP TP TP FN TP TP TP TP TP TP TP TP FN TP FN 
MJHH TP FN FN TP TP FN TP FN FN FN FN FN TP TP FN 
MJHJ FN FN FN TP FN FN TP TP TP TP TP TP TP TP TP 
MJHK TP TP FN TP TP FN TP FN FN FN TP FN FN FN FN 
*True positive, TP 
ⱡFalse positive, FN 
Table 8 Distribution of individual recall decisions for each cancer case at three recall conditions 
(S1: Free recall; S2: 15% recall; S3: 10% recall) 
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CHAPTER 5 
RADIOLOGISTS’ PERFORMANCE AT REDUCED RECALL RATES 
IN MAMMOGRAPHY: A LABORATORY STUDY 
Chapter 5 is submitted as: 
N. Mohd Norsuddin, C. Mello-Thoms, W. Reed, B.P.Soh, S. Lewis. Radiologists’ 
performance at reduced recall rates in mammography: A laboratory study. The Breast 
Journal. (2017). (TBJ-00165-2017.R1) 
 106 
 
STATEMENT FROM AUTHOR 
Statement from authors confirming authorship contribution of the PhD candidate 
As co-authors of the paper “Radiologists‟ performance at reduced recall rates in 
mammography: A laboratory study”, we confirm that Norhashimah Mohd Norsuddin has 
made the following contributions: 
 Conception and design of the research 
 Data collection 
 Analysis and interpretation of the findings 
 Writing the paper and critical appraisal of content 
Asc. Professor Sarah Lewis 
 
Date: 21/03/2017 
Asc. Professor Claudia 
Mello-Thoms 
 
Date: 21/03/2017 
Dr Warren Reed 
 
Date: 21/03/2017 
Dr Baolin Pauline Soh 
 
Date: 21/03/2017 
 107 
 
RADIOLOGISTS’ PERFORMANCE AT REDUCED RECALL RATES 
IN MAMMOGRAPHY: A LABORATORY STUDY  
Abstract 
Rationale and objectives: Target recall rates are often used as a performance indicator in 
mammography screening programs with the intention of reducing false positive decisions, 
over diagnosis and anxiety for participants.  However, the relationship between target 
recall rates and cancer detection is unclear, especially when readers are directed to adhere 
to a predetermined rate. The purpose of this study was to explore the effect of setting 
different recall rates on radiologist‟s performance.  
Materials and Methods: Institutional ethics approval was granted and informed consent 
was obtained from each participating radiologist. Five experienced breast imaging 
radiologists read a single test set of 200 mammographic cases (20 abnormal and 180 
normal). The radiologists were asked to identify each case that they required to be recalled 
in three different recall conditions; free recall, 15% and 10% and mark the location of any 
suspicious lesions.   
Results: Wide variability in recall rates was observed when reading at free recall, ranging 
from 18.5% to 34.0%. Readers demonstrated significantly reduced performance when 
reading at prescribed recall rates, with lower sensitivity (H=12.891, P=0.002), case 
location sensitivity (H=12.512, P=0.002) and ROC AUC (H=11.601, P=0.003) albeit with 
an increased specificity (H=12.704, P=0.002). However, no significant changes were 
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evident in lesion location sensitivity (H=1.982, P=0.371) and JAFROC FOM (H=1.820, 
P=0.403). 
Conclusion: In this laboratory study, reducing the number of recalled cases to 10% 
significantly reduced radiologists‟ performance with lower detection sensitivity, although a 
significant improvement in specificity was observed. 
Keywords: Recall rates, sensitivity, specificity, reader‟s performance, screening 
mammography 
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Introduction  
A comparison of international screening programs has shown a wide range of recall rates 
in clinical practice across different countries, from 1.4% in the Netherland to 15% in the 
United States (US) for the first mammography screening examination (1). Recalling a large 
number of women is considered to improve the number of cancers detected, however 
previous comparative studies have demonstrated that high recall rates do not significantly 
improve the cancer detection rate (2, 3). Additionally, a higher recall rate may only 
contribute to a substantial increase in false positive findings which may result in 
unnecessary assessments, patient anxiety and additional financial costs hampering the 
success of breast screening programs (4-6).  
The positive correlation between false positive results and recall rates (7)  has 
prompted many screening programs to impose specific recall targets in order to optimize 
the trade-off between recall rates and cancer detection. These recall policies are also used 
to evaluate the performance of breast readers in the respective programs and provide 
guidelines for best practice. Variation also exists within screening mammography 
programs, with higher target recall rates for the first or initial screening as compared to 
subsequent screening. For example, BreastScreen Australia (BSA) suggests that the 
clinical recall rate should be at 10% for initial screens with a recall rate for subsequent 
screening at 5% (8, 9).  
Extensive studies have shown varying results regarding an appropriate recall rate 
that will give the best trade-off between recall rates and cancer detection rates (10-12). A 
prospective study by Yankaskas et al. (2001) suggested screening practices at recall rates 
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between 4.9% and 5.5% will yield efficiency in cancer detection versus false positive 
results, whereas subsequent work by Schell et al. (2007) demonstrated maximum 
sensitivity and minimal false positives occurred at a 10% recall rate for the first screening 
and at 6.5% for subsequent screening (10, 12).  Another study from the Netherlands has 
indicated that recall rates of more than 4% only contribute to a higher number of false 
positive decisions, not the number of cancers detected (11).  
The purpose of this study was to explore the effect of setting varying recall rates on 
the performance of radiologists viewing the same test set of images over three separate 
reading sessions. We have explored this through a methodology that assesses the 
radiologists‟ ability to correctly locate lesions and give a confidence rating based on the 
decisions.  
Materials and Methods 
Institutional ethical approval was granted and informed consent was obtained from all 
participants involved in this study. It was performed at the Medical Imaging Optimisation 
and Perception Group (MIOPeG) laboratory at the Brain Mind Centre (BMC) of the 
University of Sydney between February 2015 and January 2016.  
Participants 
Five experienced radiologists who specialized in breast imaging with a median of 15 years 
(range, 9 to 26 years) of experience of interpreting mammograms, reading between 3500 
and 30000 (median, 8000) mammograms each year and spent a median of 10 hours a week 
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reading mammography cases volunteered to participate in this study (Table 1). The 
participating radiologists were given a small gift voucher as an expression of gratitude for 
their participation on completion of the study.  
Table 1 Demographic details of participating radiologists 
Reader number Number of years 
of experience 
Number of 
mammography cases 
read per year 
Number of 
hours per week 
reading 
mammograms 
1 15 30 000 10 
2 26 10 000 3 
3 15 10 000 10 
4 9 6 000 24 
5 20 3 500 6 
Median 15 8 000 10 
  
Experimental protocol 
Cases 
A test set containing 200 de-identified digital mammographic examinations obtained from 
the BreastScreen NSW (BSNSW) digital imaging library was presented in a randomized 
order to each reader for three separate reading sessions. Each case comprised two 
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mammographic views, the cranio-caudal (CC) and the medio-lateral oblique (MLO) 
respectively of each breast. There were 180 cases with normal findings and 20 cases with 
abnormal findings in the test set; all the abnormal cases contained a single biopsy-proved 
malignancy. An expert breast radiologist who is involves in training assessment, quality, 
clinical policies of BreastScreen NSW and also has responsible for clinical management of 
a screening center then identified the „truth‟ locations of all malignant cases. The expert 
did not participate as an observer in this experiment and had access to prior images with 
biopsy confirmed malignancy results. Normal cases were validated after 2 years normal 
screening follow up. 
Reading environment  
This longitudinal study was divided into three separate reading sessions. Each 
session had a different recall rate condition and was separated from the previous reading by 
a minimum of two months to reduce any memory effects. The total study time was six 
months for the three reads for each reader. At the first reading session, no numerical 
percentage recall rate was imposed and readers were tasked with a “free recall” when 
interpreting the cases; that is, they could recall as many cases as they believed necessary. 
In the second session, the number of mammographic cases that readers could recall was set 
at 30 cases (15%), and reduced to 20 cases (10%) for the third reading. 
The laboratory reading environment was designed to be as authentic to the clinical 
environment as possible, using an identical clinical workstation as used by BreastScreen 
New South Wales (BSNSW), Australia. All images in the test set were displayed on a pair 
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of five-megapixel (5MP) EIZO Radioforce GS510 medical-grade monitors (Ishikawa, 
Japan) with ambient lighting maintained at 20 to 40 lux throughout the reading sessions. 
Prior to study commencement, calibration was performed on the monitor displays to 
adhere to the Digital Imaging and Communications in Medicine (DICOM) Part 14 
Standard (13). 
Reading Task 
Figure 1 shows the flowchart process of the study methodology. During the reading 
sessions, readers identified each mammographic case that they considered malignant in 
keeping with their free or specified target recall rate. Following that, readers used 
customized recording software to mark the location of any suspicious lesions from the 
recalled cases. This software was designed to record all the coordinates of marked lesions 
for each of the recalled cases on a laptop adjacent to the two 5MP monitors.  Readers were 
not permitted to exceed their target recall rates and the software provided a continuously 
updated count on the number of cases marked as “recall”. All lesions marked on each 
recalled case were given a confidence score ranging from 1 to 5, with a greater number 
indicating a higher confidence of malignancy. A score of 1 or 2 indicated a normal and 
benign lesion respectively. A 60-pixel acceptance radius surrounding each lesion was 
considered the acceptable radius as it encompassed the largest lesion present in the test set. 
A lesion was considered correctly detected when the location was within 60 pixels from 
the center of the true location of the cancer and it was given a confidence score between 3 
to 5.  
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Readers were not provided with any clinical information associated with the cases 
including the prevalence of abnormal cases and no prior images were available. The 
readers had unlimited time and were able to scroll back through the cases if they wished to 
alter their decision or needed to reduce the number of cases recalled to align with the 
specific target recall rate condition. Readers were also able to digitally manipulate the 
images including windowing, zooming and panning as in the actual clinical setting.  
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Data Analysis 
For all reading sessions, reader performance was assessed using sensitivity, 
specificity, case location sensitivity, lesion location sensitivity, receiver operating 
characteristic (ROC) area under the curve (AUC) and Jack-knife free-response ROC 
(JAFROC) figure of merit (FOM). The marked lesions were identified either as positive or 
negative by comparing selections with the truth table compiled by the expert breast 
radiologist. All performance data were analyzed using JAFROC Version 4.2 software and 
statistical analysis was performed using SPSS software version 22.0.  
A true positive was scored if a lesion was marked within the acceptance radius and 
received a confidence score between 3 to 5. A false positive was defined for any incorrect 
localization on normal or benign cases, or if it was outside the 60 pixels range of a lesion 
in abnormal cases. A true negative outcome was recorded if the case was correctly 
identified as normal or lesion-free. A false negative was scored when cancer lesions were 
not marked. The performance metrics used for this study are explained as follows:  
 Sensitivity was defined as the proportion of abnormal cases correctly identified by 
the reader.  
 Specificity was defined as the proportion of normal cases correctly identified by the 
reader.  
 Case location sensitivity measures the proportion of positive cases correctly 
marked, where at least one lesion was correctly identified on the correct location in 
the case. 
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 Lesion location sensitivity is the proportion of positive lesions correctly marked; it 
was calculated by dividing the number of lesions correctly detected by the total 
number of positive/abnormal lesions, where the positive lesions detected were on 
the correct locations for each lesion. 
 ROC analysis is a binary paradigm focused on a single rating per case. In this study 
a TP score was given to a case when the reader correctly identified the correct side 
of the breast containing cancer, without the need to show the specific location of 
the lesion. 
 JAFROC analysis is a free-response paradigm that allows lesion location 
information to be included when analysing reader performance.  
The analysis was done in two steps. Firstly, a Kruskal-Willis test was performed across 
the three reading sessions with statistical significance set at P < 0.05. Secondly, post-hoc 
analysis using the Mann-Whitney U test was performed to identify which groups were 
significantly different from each other. For this purpose, Bonferroni adjustment was 
applied to the alpha values by dividing the alpha level by the number of comparisons 
made. Results with the revised alpha level, P < 0.017, were deemed to represent significant 
differences.  
Results  
Table 2 demonstrates the readers‟ scores for all performance metrics; sensitivity, 
specificity, case location sensitivity, lesion location sensitivity, ROC AUC and JAFROC 
FOM at the conditions of free recall, 15% and 10% recall rate. The median recall rate for 
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all readers when reading at free recall was 25.0% and ranged from 18.5% to 34.0%, which 
was higher than that recommended by BreastScreen Australia for initial screening (10%). 
By limiting the number of recalled cases (from free recall to 10% recall rate), readers 
demonstrated reduced performance, with a decrease in sensitivity (from median 0.80 to 
0.55), case location sensitivity (from median 0.80 to 0.55), lesion location sensitivity (from 
median 0.64 to 0.56), and ROC AUC (from median 0.84 to 0.75). However, there was a 
median increase in specificity from 0.81 to 0.95.  
Significant changes were observed in reduced sensitivity (H=12.891, P=0.002), 
case location sensitivity (H=12.512, P=0.002) and ROC AUC (H=11.601, P=0.003) along 
with an increased specificity (H=12.704, P=0.002) across all reading conditions (Table 3). 
No significant differences were noted for lesion location sensitivity (H=1.982, P=0.371) 
and JAFROC FOM (H=1.820, P=0.403). Although a significant difference was found in 
ROC AUC, post-hoc Mann-Whitney U test showed no significant differences in ROC 
AUC when reading at free recall and 15% (z=-2.200, P=0.028).  
. 
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Table 2 Results for sensitivity, lesion location sensitivity, case location sensitivity, specificity, ROC AUC and JAFROC FOM at free call, 15% and 10% 
conditions 
 Sensitivity Specificity Case location 
sensitivity 
Lesion location 
sensitivity 
ROC AUC JAFROC FOM 
Reader 
number 
Free 
recall 
15% 10% Free 
recal
l 
15% 10% Free 
recal
l 
15% 10% Free 
recall 
15% 10% Free 
recal
l 
15% 10% Free 
recal
l 
15% 10% 
1 0.80 0.65 0.55 0.83 0.91 0.95 0.80 0.60 0.55 0.78 0.67 0.58 0.84 0.79 0.76 0.83 0.80 0.78 
2 0.90 0.65 0.45 0.79 0.91 0.93 0.80 0.60 0.45 0.56 0.56 0.47 0.86 0.79 0.70 0.76 0.76 0.71 
3 0.90 0.65 0.55 0.72 0.92 0.95 0.80 0.65 0.55 0.81 0.67 0.56 0.84 0.79 0.75 0.80 0.80 0.76 
4 0.75 0.70 0.55  0.88  0.88 0.92 0.94 0.70 0.65 0.55 0.64 0.64 0.56 0.83 0.82 0.75 0.76 0.79 0.75 
5 0.75 0.70 0.55 0.81 0.92 0.95 0.65 0.60 0.55 0.36 0.33 0.50 0.80 0.82 0.76 0.59 0.63 0.73 
Median 0.80 0.65 0.55 0.81 0.92 0.95 0.80 0.60 0.55 0.64 0.64 0.56 0.84 0.79 0.75 0.76 0.79 0.75 
†JAFROC FOM , Jack-knife free-response figure of merit 
ⱡROC AUC , Receiver operating characteristic area under the curve 
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Table 3 Kruskal-Wallis analysis and post hoc Mann-Whitney U test of sensitivity, lesion 
location sensitivity, case location sensitivity, specificity, ROC AUC and JAFROC FOM 
 
Kruskal-Wallis 
Test 
Post-hoc test (Mann-Whitney U test) 
 Free recall VS 
15% 
15% VS 10% Free recall 
VS  
10% 
  
P value (P < 
0.05) 
P value (P < 0.017) 
Sensitivity 0.002* 0.008* 0.006* 0.007* 
Specificity 0.002* 0.008* 0.007* 0.008* 
Case Location 
Sensitivity 
0.002* 0.013* 0.006* 0.006* 
Lesion Location 
Sensitivity 
0.371 0.598 0.243 0.245 
ROC AUC 0.003* 0.028 0.009* 0.009* 
JAFROC FOM 0.403 0.917 0.251 0.251 
*Values shown in bold represent statistically significant difference 
†JAFROC FOM , Jack-knife free-response figure of merit 
ⱡROC AUC, Receiver operating characteristic area under the curve 
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Discussion 
Varied specified recall rates have been introduced by various national and 
international organizations as a guideline for optimizing the performance of their breast 
screening programs. However, there is a lack of evidence supporting the actual effect of 
differing target recall rates upon radiologists‟ performance. Our results show that each of 
the five readers‟ sensitivity was highest when operating in the free recall condition as 
compared to a reduced specified recall rate, with a higher median ROC AUC (0.84) and a 
JAFROM FOM (0.73). When the readers were tasked with reducing their recalled cases 
from free recall to specific recall rates (15% and 10%), their performance declined 
noticeably, with a significant reduction in sensitivity, case location sensitivity and ROC 
AUC.  
 The higher sensitivity at higher specified recall rates observed in our study is in 
agreement with Gur et al and Schell et al, who suggest that recalling more cases may result 
in a higher cancer detection rate (7, 12). However, the effectiveness of a breast screening 
program is not merely dependent on the number of cancers detected but also in reducing 
the number of unnecessary recall among screened women. It is well documented that false-
positive recalls are associated with psychological consequences and economic burden (14-
19).  
In the current study, readers demonstrated a significant improvement in their 
specificity as recall rates reduced (P=0.002). By lowering the number of cases allowed to 
be recalled, readers may have needed to sacrifice some cases that they considered to be 
abnormal at a higher recall rate, which in turn resulted in fewer false positive decisions. 
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The increased specificity observed here concurs with previous findings by Otten et al and 
Elmore et al, where higher recall rates correlated with an increase in false positive findings 
and lower specificity (1, 11).  
Comparing our results directly with previous studies in the literature is complex as 
we began our reading sessions with the highest recall rate (free recall) and stepped it down 
to 15% and then 10% which complied with the Australian standard for the first screening 
recall rate. In the Dutch study by Otten and colleagues (2005), they reported the effect of 
increasing recall rates up to 10% on cancer detection, with the best efficiency between 
cancer detection and specificity seen at recall rates below 5%. Otten et al found that 
between recall rates of 0.9 and 4.0%, the cancer detection rate increased approximately 
17.0% respectively. However, when they modeled a further increase in the recall rate 
above 5%, the results suggested a relatively small increase in the cancer detection rate 
(approximately 0.6%), with a higher number of false positive results (11).  
Similarly, Yankaskas et al (2001) also reported a positive effect between recall rate 
and sensitivity at recall rates of 5%. As the recall rates increased to 13.4%, a non-
significant increase in sensitivity was observed in this prospective study (10). In our 
current work, we were unable to test the effect of lowering the recall rate further to 5% due 
statistically to the number of cancer cases in the test set of 200. However, the readers in 
our study demonstrated their best cancer detection at free recall, with a significant decrease 
in sensitivity at 15% and 10% respectively. In acknowledging a difference in study 
outcomes, the best explanation may lie in the variation between reading in the clinical 
environment and our experimental design. Also in contrast to our study in the research by 
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Otten et al (11) and Yankaskas et al (10), the previous clinical information and prior 
images were available potentially altering reader performance (20, 21).  
Although small reductions were seen in lesion location sensitivity, there was no 
statistically significant difference for this performance metric at lower recall rates. 
Conversely, case location sensitivity demonstrated significant differences across all 
reading conditions. The discrepancy in these results may be explained by the fact that 
lesion location sensitivity has a stricter criterion in decision making, where readers must 
correctly identify the location of the lesion for every lesion in cancer cases. In contrast, the 
criterion applied for case location sensitivity was for readers to correctly identify where at 
least one lesion was marked in each case. It also interesting to note that, at an individual 
level, reader 5 demonstrated a substantial difference in lesion location sensitivity values 
(below 0.40) as compared to the other four readers, regardless of the recall rate conditions, 
without a significant change in the case location sensitivity. In this example, we see the 
clinical reporting behaviour of readers, whereby this reader noted they are more likely to 
mark only one mammographic view for a case that required further assessment, rather than 
lesion-specific marking as per our instructions. The reader may have considered the task 
done if located on just one image as this is still a recall in clinical practice. To our 
knowledge, no commentary on the effect of recall rates on readers‟ performance has been 
reported using JAFROC analysis from the prior studies. With greater statistical power over 
traditional methodologies reporting observer‟s performance, such as ROC (22, 23), our 
data yielded no significant differences in JAFROC FOM as observed across all reading 
sessions. Quite simply, in the true positive cases that the radiologists did recall, they were 
able to identify the lesion location with good precision. 
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Although a 10% recall rate in our final specified target recall rate is the same as 
Australian clinical practice for the first mammographic screening, often readers are not 
held to this in a strict sense. All five readers in our study demonstrated a higher individual 
recall rate (free recall) ranging from between 18.5% and 34.0% when no limitation was 
imposed. This result may be because the readers were aware that the study was conducted 
in laboratory conditions and their decisions would not influence patient care and no 
patients would actually be recalled.  The readers may also have been expecting a higher 
number of abnormalities, or an enriched test set, in a laboratory study (20, 24). 
Additionally, the removal of clinical history and prior images in the test set may have 
affected their behavior when interpreting the mammograms as they usually have access to 
this additional information in clinical practice and more likely to recall in these 
circumstances to be on the safe side. 
Our study was designed to resemble clinical mammography practice, hence there 
was a requirement to use a reasonably high number of cases (n=200) and images (n=800). 
Therefore fatigue may be present for some readers and this may have contributed to some 
loss of attention, particularly for difficult to detect lesions (25). Our sample consisted of 
highly experienced radiologists (median of 15 years) with more than 3000 mammographic 
cases reading per year, which may have contributed to the similarity in their performance. 
A larger study with a diversity of reader experience and case load would allow clarification 
of the importance of experience when adhering to specific recall rates. It would be 
interesting to explore how readers with a range of experience adhere to different recall 
rates and also how varying recall rates would affect the readers‟ performance, and may 
yield some important relationships between lesion location sensitivity and experience. 
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Nevertheless, current data from our preliminary work has demonstrated important 
empirical evidence on how limiting the number of recalled cases in screening can impact 
on the behavior of readers. A unique aspect of this study is that recall rates were controlled 
by treating predetermined recall rates as the primary indicator; a confounder known to 
increase variability in past studies (10-12).  
Conclusion 
In summary, our data suggests that specific target recall rates caused a significant reduction 
in readers‟ sensitivity with an associated increase in specificity. However, no differences in 
readers‟ JAFROC scores were demonstrated, indicating a level of consistency in readers 
identifying and locating lesions within this test set. Reducing recall rates by enforcing a 
specific target recall rate may result in a corresponding reduction in cancer detection and 
may impact on the behaviour of readers in their recall-decision strategies for abnormal 
cases. Further work on how specific lesion features or characteristics were reflected in the 
readers‟ recall decision is required to understand further the nature of improved the balance 
between true and false positive decisions. 
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AN INVESTIGATION INTO THE MAMMOGRAPHIC 
APPEARANCES OF MISSED BREAST CANCER WHEN RECALL 
RATES ARE REDUCED 
Abstract 
Objectives: This study investigated whether certain mammographic appearances of breast 
cancer are missed when radiologists read at lower recall rates. 
Methods: Five radiologists read one identical test set of 200 mammographic (180 normal 
cases and 20 abnormal cases) three times and were requested to adhere to three different 
recall rate conditions: free recall, 15% and 10%. The radiologists were asked to mark the 
locations of suspicious lesions and provide a confidence rating for each decision. An 
independent expert radiologist identified the various types of cancers in the test set, 
including the presence of calcifications and the lesion location including specific 
mammographic density. 
Results: Radiologists demonstrated lower sensitivity and receiver operating characteristic 
(ROC) area under the curve (AUC) for non-specific density (NSD)/asymmetric density 
(H=6.27, P=0.04 and H=7.35, P=0.03 respectively) and mixed features (H=9.97, P=0.01 
and H=6.50, P=0.04 respectively) when reading at 15% and 10% recall rates. No 
significant change was observed on cancer characterized with stellate masses (H=3.43, 
P=0.18 and H=1.23, P=0.54 respectively) and architectural distortion (AD) (H=0.00, 
P=1.00 and H=2.00, P=0.37 respectively). Across all recall conditions, stellate masses 
were likely to be recalled (90.0%) while NSDs were likely to be missed (45.6%).  
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Conclusion: Cancers with a stellate mass were more easily detected and are likely to 
continue to be recalled, even at lower recall rates. Cancers with non-specific density and 
mixed features were most likely to be missed at reduced recall rates.  
Advances in knowledge:  
Internationally, recall rates vary within screening mammography programs considerably, 
with a range between 1% to 15% and very little is known about the type of breast cancer 
appearances found when radiologists interpret screening mammograms at these various 
recall rates. Therefore, understanding the lesion types and the mammographic appearances 
of breast cancers that affected by readers‟ recall decisions should be investigated.  
. 
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Introduction 
Several studies have demonstrated substantial variability in recall rates among radiologists 
reporting in breast screening programs, with large international variations ranging from 1% 
to 15.1%.
1-3
 Although many countries use the Breast Imaging Reporting and Data System 
(BIRADS) as a standardized method of reporting mammograms, a considerable variability 
in assessment is still seen, even when reporting the same mammographic images by 
different readers. 
1, 4-6
  
Many factors influence the difficulty of reaching a correct diagnosis for normal and 
abnormal cases. Specific mammographic lesion features have been found to significantly 
contribute to cancer detection, especially lesion conspicuity.
7
 Ikeda et al found that 22% of 
missed cancers in the Malmo Screening Trial showed subtle mammographic signs of 
malignancy, with lesions that present with architectural distortion (AD) being the most 
challenging malignancy feature for readers to detect.
8
 Furthermore, dense breast tissue has 
been found to be a strong confounder for lesion detection and cases with high 
mammographic breast density were more likely to be recalled.
9-11
  
With a large variation in the recommended target recall rates within screening 
mammography programs internationally 
12-14
, very little is known about the 
mammographic features or breast cancer appearances which are affected by recall 
decisions at reduced rates. A recent study by Onega et al 
15
 with 119 radiologists reading 
109 screening mammograms found low recall agreement for lesions with architectural 
distortions (AD) and asymmetric densities features. Identifying cancer appearances that are 
more likely to be missed when recall rates are reduced is clinically important because it 
can inform readers‟ decisions in recalling women for further assessment. Therefore, the 
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purpose of this study was to investigate which types of mammographic appearances of 
breast cancer are most likely to be missed when radiologists read at lower recall rates. 
Materials and methods  
Sample 
Institutional ethics approval was granted for this study (Project number: 2014/484). Five 
breast radiologists who reported for BreastScreen New South Wales (BSNSW) with 15 to 
26 years of experience participated in this study.  The radiologists read between 2,000 and 
30,000 (median 8,000) mammograms each year and spent a median of 10 hours a week 
reading mammography cases. 
Cases 
A test set of screening mammograms, comprising of 200 cases, was obtained from the 
BSNSW digital imaging library.  An enriched test set containing 180 normal cases and 20 
abnormal cases, with each abnormal case containing a single biopsy-proved malignancy, 
was obtained. Each mammographic examination consisted of a two-view digital 
mammogram, a cranio-caudal view (CC) and a medio-lateral oblique (MLO) of both 
breasts with a range of lesion conspicuity, from subtle to obvious cancer presentations and 
a variety of normal mammographic appearances. In 16 cases the cancer was visible on both 
mammographic views (CC and MLO) of a given breast, while four cases had a visible 
lesion on either one of the mammographic views, which resulted in a total of 36 malignant 
lesions available for localization. The “truth” locations and mammographic appearances of 
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all malignant cases were identified by an expert radiologist (M.R), who is involved in 
training, quality assessment, clinical policies of BreastScreen NSW and also is responsible 
for the clinical management of a screening centre. This expert radiologist had access to the 
biopsy report and prior images, which assisted in determining the location and the 
mammographic appearances of the abnormalities based on the Australian Synoptic Breast 
Imaging Report of the National Breast Cancer Centre (NBCC) that is endorsed by the 
Royal Australian and New Zealand College of radiologists (RANZCR).
16, 17
  Normal cases 
were validated after 2 years normal screening follow up. Lesion descriptors used in this 
study have been defined in Table 1.  
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Table 1 Definition of lesion terms used  for classification 
17
 
Lesion abnormalities  Definition  
Calcification Deposition or collections of calcium compounds in breast tissue of 
sufficient size to be seen on mammogram and malignancy is 
characterised by size (0.05-0.5mm), distribution (cluster, multiple 
cluster, or sometimes scattered), pleomorphism and variation of 
density.  
Stellate lesion Spiculations of variable length radiating from a central point or mass 
characterized with small or large, and of low, mixed or high density 
compared to surrounding breast parenchyma. 
Architectural distortion Abnormal configuration of the ductal and ligamentous structures of 
breast parenchyma compared with the remainder of the breast tissue 
markings and often appears with spiculation, focal retraction, 
distortion of the parenchymal edge, and disorganisation of markings. 
Non-specific density Asymmetry of breast tissue seen in one of the breasts, on either one 
or two mammographic views with poorly defined characteristics of 
breast density.  
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The categories of mammographic cancers‟ appearances were: stellate, AD, non-specific 
density (NSD), mixed appearance of calcification and AD, and stellate and NSD. The 
mammographic appearances of the cancer lesions were classified into three categories: 
lesion type, breast density and location of the lesions in the images.  Breast density was 
graded according to the Breast Imaging Reporting and Data System, BI-RADS criteria, 4
th
 
edition:  1–the breast is almost entirely fat (<25% glandular), 2-there are scattered 
fibroglandular densities (approximately 25–50% glandular), 3-the breast is 
heterogeneously dense (approximately 51-75% glandular) or 4–the breast tissue is 
extremely dense (>75% glandular). 
Reading sessions 
This study was conducted in a laboratory reading environment designed to closely 
resemble the clinical environment, with all images displayed on the same calibrated, high-
specification workstation with five-megapixel EIZO Radioforce GS510 medical-grade 
monitors (Ishikawa, Japan). Readers were required to read all the 200 mammographic 
cases in three separate reading sessions using different recall rates.  At the first reading 
condition, no numerical percentage recall rate was imposed and readers were tasked with a 
“free recall” when interpreting the cases; that is, they could recall as many cases as they 
believed necessary. In the second condition, the number of mammographic cases that 
readers could recall was restricted to 30 cases (15%) based on international recall rates, to 
reflect 15.1%  in the United States.
3
 For the third session, readers were restricted to recall 
only 20 cases (10%) to align with the first screening recall required by BreastScreen 
Australia. To reduce any memory effect, each reading session was separated by a 
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minimum of two months and the reading order of images was randomized for each reading 
session and each reader. 
Reading task 
During the three reading sessions, readers indicated whether they would recall or not recall 
the mammographic cases as per their usual clinical practice for BreastScreen Australia. For 
each recalled case, readers were required to mark the location of the detected lesions on 
both mammographic views and score them on the scale of one to five (with five being the 
highest confidence of malignancy) using a custom made recording software. This scoring 
system is aligned to BreastScreen Australia practice for classifying mammographic lesions; 
a score of 1 and 2 indicated a normal and benign decision respectively, and a score of 3, 4 
or 5 would be considered as a recall for assessment. Readers were not permitted to exceed 
their target recall rates at the end of each recall condition, however, if they exceeded 
during the reading session, the readers were able to scroll back through the cases and alter 
their decision to ensure the number of cases recalled aligned with the prescribed target 
recall rate condition. Readers were also able to digitally manipulate the images including 
windowing, zooming and panning as in the actual clinical setting. For the purpose of 
simulating the first screening read, no prior images or clinical history were provided during 
the three reading sessions. The readers were not aware of the prevalence of abnormal cases 
in the test set. 
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Data analysis  
Reader performance was assessed by sensitivity and receiver operating characteristic 
(ROC) area under the curve (AUC). Sensitivity was defined by the proportion of cancers 
correctly marked by readers. Even though the readers were encouraged to mark a perceived 
lesion on both views, for analysis purposes, a true positive (TP) was assigned when the 
reader correctly marked it in one -view of the positive breast only. All marked lesions were 
compared with those contained in the truth table. A significant difference of both metrics 
was compared across the three recall conditions using a non-parametric Kruskal-Wallis 
test. The false positive rate was calculated by the number of false positive decisions made 
on normal cases divided by the total number of normal cases.  
Further analysis for this study focused on determining whether the detection of any 
specific cancer types was altered when the recall rates were reduced (Condition 15% and 
10%), which narrowed the analysis to the 20 abnormal cases only and the analysis was 
performed at a case-based level. Cancer difficulty was scored out of 15, which was the 
total number of readers (n = 5) multiplied by the number of reading conditions (n = 3).  
Cancer difficulty was then classified as the sum of lesions that were correctly marked 
throughout all recall conditions resulting in three difficulty levels as follows; 
1. Lower difficulty: Lesion in the case was correctly marked by readers at least 12 
times across the 3 reading conditions 
2. Medium difficulty: Lesion in the case was correctly marked by readers between 5 
to 11 times across the 3 reading conditions 
3. Higher difficulty: Lesion in the case that was marked by readers less than 5 times 
across the 3 conditions 
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Figure 1 Examples of lesion features present in this study a) stellate mass; b) mixed features of 
calcification and architectural distortion (AD); c) non-specific density (NSD) 
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Results  
For each cancer type, our results demonstrated that readers have higher sensitivity (0.80) 
and ROC AUC (0.84) when reading at the free recall (mean recall rate of 25.6%) condition 
as compared to 15% (0.65 and 0.79 respectively) and 10% (0.55 and 0.75 respectively).  
Changes in sensitivity at 15% and 10% recall rates were compared against the 
baseline free recall using ROC AUC. There was a significant decrease in sensitivity at 15% 
and 10% for NSD (H=6.27, P=0.04 and H=7.35, P=0.03 respectively), and for mixed 
features (H=9.97, P=0.01 and H=6.50, P=0.04 respectively). There was no significant 
difference in sensitivity at 15% and 10% for stellate lesions (H=3.43, P=0.18 and H=1.23, 
P=0.54 respectively), and AD (H=0.00, P=1.00 and H=1.23, P=0.37 respectively) (Table 
2). An average false positive rate of 0.17 (range 0.12 to 0.21) was observed for free recall, 
0.08 (range 0.08 to 0.09) for 15% and 0.05 (range 0.05 to 0.06) for 10%. 
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Table 2 Mean values of sensitivity and receiver operating characteristic (ROC) area 
under the curve (AUC) of each mammographic feature at free recall, 15% and 10% 
recall rates 
 Lesion type Mean sensitivity  P value 
 
Free 
recall 
15% 
recall 
10% 
recall 
 
     
Stellate 0.95 0.90 0.83 0.180 
AD 0.80 0.80 0.80 1.000 
NSD 0.67 0.47 0.20 0.043* 
Mixed features   0.80 0.45 0.30 0.007* 
     
 
Mean ROC AUC P value 
 
Free 
recall 
15% 
recall 
10% 
recall  
Stellate 0.93 0.93 0.89 0.541 
AD 0.81 0.86 0.88 0.368 
NSD 0.75 0.70 0.58 0.025* 
Mixed features 0.79 0.68 0.62 0.039* 
*Significant differences (P<0.05)     
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Table 3 shows an analysis of mammographic appearances of cancer cases in relation to 
case difficulty at free recall, 15% and 10% recall rates. Ten cancer cases were grouped as 
„lower difficulty‟ cases with six of the cancers characterized with stellate masses. Cancers 
with NSD were the most common cancer features found among eight cases in the „medium 
difficulty‟ group. The „higher difficulty‟ cases were characterized with NSD and mixed 
features of calcification+AD.  
In this study, cancers characterized with stellate mass features were most likely to 
be recalled by all five readers regardless of any recall conditions. At the 15% recall 
condition, cancer with mixed features of calcification+AD (for example, MJAS) showed 
the highest reduction in recall decisions (from 5 to 1), followed by cancers with NSD (from 
4 to 1). When the recall rate was further reduced to 10%, six cancers were less likely to be 
recalled, with all of these cases having been recalled at „free recall‟ and 15% recall, but 
missed by all readers at the 10% recall condition. NSD was found to be the most common 
feature that was missed by all readers at the 10% recall, followed by cancers with mixed 
features of calcifications+AD and stellate+NSD. It is noted that two cancers with AD 
features showed an increase in detection at 15% (from 3 to 5) and 10% recalls (from 3 to 
4).  
When considering the lesion type and mammographic breast density together, the 
analysis revealed most of the cancers in the lower difficulty group were in cases with low 
mammographic density (≤50% glandular, BIRADS 1 or 2) (see Table 3). Conversely, a 
greater number of cancers in the medium difficulty and higher difficulty group were 
located in cases with high mammographic density (≥51% glandular, BIRADS 3-4). 
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Table 3 Distribution of detection and cancer appearances (lesion type, breast density 
and lesion location) for each cancer in relation to case difficulty at free recall, 15% and 
10% recall rates.  
Case 
ID 
Number of readers 
detected cancer for 
each reading 
session 
Total Lesion type Breast density 
(BIRADS) 
  
Free 
recall 
15% 10%     
 
Lower difficulty  
 
MJBL 5 5 5 15 Stellate >75% 
MJCX 5 5 5 15 Stellate < 25% 
MJDA 5 5 5 15 Stellate 51-75% 
MJEA 5 5 5 15 Stellate 25-50% 
MJGR 5 5 5 15 Stellate 25-50% 
MJDH 5 5 5 15 Stellate 51-75% 
MJCQ 5 5 4 14 NSD 51-75% 
MJEG 5 4 3 12 Calcifications + AD 25-50% 
MJBJ 5 3 4 12 AD 25-50% 
MJHD 3 5 4 12 AD  < 25% 
  
Medium difficulty 
 
MJHJ 4 3 3 10 Stellate 51-75% 
MJAS 5 1 3 9 Calcifications + AD >75% 
MJBK 3 3 2 8 NSD 51-75% 
MJCR 4 3 1 8 Stellate 25-50% 
MJDU 3 3 0 6 Stellate + NSD 51-75% 
MJHH 4 2 0 6 NSD 25-50% 
MJHK 3 3 0 6 NSD  25-50% 
MJEB 4 1 0 5 NSD  51-75% 
  
High difficulty  
 
MJBG 3 1 0 4 Calcifications + AD 51-75% 
MJCF 1 1 0 2 NSD >75% 
        
 
  
 
*AD, architectural distortion 
ⱡNSD, non-specific density 
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Figure 2 All three cancers above characterized with non-specific density (NSD) but with variability in 
lesion detectability and level of difficulty at reduced recall rates; a) MJCQ: lower difficulty; b) 
MJBK: medium difficulty and c) MJCF: higher difficulty. 
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Discussion 
This study provides a unique perspective on the variability in mammographic 
interpretation by evaluating the mammographic appearances/features that were more likely 
to be recalled when recall rates are reduced. In agreement with our findings, a recent study 
by Onega et al 
15
 has shown that asymmetric densities contributed to low agreement for 
recall cases.  
 In this study, readers were able to recall cancers with stellate masses regardless of 
any recall condition. Retrospective analysis of the 20 cancer cases has demonstrated that 
cancers characterized with NSD were less likely to be recalled as soon as the readers were 
asked to reduce their recall rate to 15% and 10%. NSD was then followed by cancers with 
mixed features, which in this study were calcifications+AD and stellate+NSD. This is 
likely due to their subtle and indirect signs of malignancy. These subtle features of 
malignancy have been recognized in previous studies as being frequently missed by 
readers.
8, 18-20
 A study by Duncan et al 
20
 when reviewing the mammographic features of 
112 incidental screen-detected cancers, found greater asymmetric density and parenchymal 
deformity in the missed cancers than in those detected. Readers may have also interpreted 
irregular opacities in NSD as benign in breasts composed of tissue with irregular densities 
which do not warrant recall.
21, 22
  
Considering the features of cancer lesions are varied, past research has shown that 
cancers that present with mixed appearances (more than one mammographic feature) are 
more likely to be missed and readers are more susceptible to omission error when cancers 
display mixed mammographic appearances.
23
 Our study supports this, whereby the  
mammographic features of stellate lesions were associated with spiked linear extensions 
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radiating outwards and  ill-defined spicules from the central lesion which indicate the 
demosplastic reaction of breast cancer into surrounding tissue.
24
  The distinctive features of 
stellate lesions have a positive predictive value (PPV) of 84%-91% and are most common 
mammographic features of invasive breast cancer.
25
 These features were easily recognized 
by our readers and were recalled for further assessment. However, when stellate features, 
were associated with other mammographic features, such as NSD with ill-defined borders 
or AD, these lesions became less suspicious and hence were not recalled at lower rates.  
Similarly, cancers characterized by combination features of calcifications and AD are less 
likely to be recalled than cancers with AD alone, although in a study by Craft et al 
26
 found 
up to 48% of cancers with calcifications were associated with malignancy. Calcification 
has also been found to have uncertain malignant potential when associated with atypical 
breast lesions.
27
 It is interesting to note that we also found inconsistency in readers‟ 
decisions when recalling cancers characterized with AD. Unlike other cancer features, the 
fine linear structures of AD normally seen on mammograms can resemble superimposed 
normal breast tissue, but it also can appear as a stellate shape and an accompanying feature 
of other abnormalities, which turn out to be a breast cancer. A recent study on the ability of 
readers to detect AD by Suleiman et al
28
 has shown that readers had greater difficulty 
detecting cancers with AD than other cancer features, with significantly lower sensitivity 
and receiver operating characteristic (ROC) area under the curve (AUC) results. With the 
limited number of cases that were allowed to be recalled in the conditions of 15%, and 
10% recall rates, several features of AD such as trabecular thickening, which disrupt the 
normal breast tissue pattern, may also lead to uncertainty in readers‟ decision-making, 
resulting in recalling for further assessment. 
15, 28
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Other perceptual factors such as mammographic density may have an attractor and 
distractor effect that also influenced recall decisions.
10, 29-32
  Our high difficulty cases 
occurred in conjunction with high mammographic density. In addition, higher 
mammographic density may also increase the likelihood of cancers being missed in 
mammography.
10, 29-32
 In this study, cancers within cases of low mammographic density 
(BIRADS 1 and 2) were more likely to be recalled and cancers present in cases with higher 
mammographic density (BIRADS 3 and 4) were likely to be missed. With some limitations 
specific to two dimensional (2D) mammography, it is possible that lesions with subtle 
malignancy signs such as NSD might be obscured by dense parenchyma. This finding is 
concurrent with earlier findings by Bird et al 
19
 who reported that 24% of missed cancer in 
screening mammography were due to higher mammographic density. Additional views 
such as coned compression or magnifications, which give better contrast and spatial detail 
on the targeted area, were not available to our readers and may have improved recognition 
of the lesions; however, these views are not part of a standard screening protocol. Further 
research in this area employing eye-tracking analysis may aid in understanding the visual 
search patterns of readers making their decisions under strict recall conditions. An 
additional area for further research may include the role of training to improve the 
identification of more difficult lesions, including the effect of experience upon consistent 
recalling of certain lesion types.   
 Reflecting on the clinical significance of the results of this study, the fact that the 
readers continued to recall stellate lesions even at reduced recall rates may be due to the 
biological significance of these findings. This is because stellate lesions are often  
recognised as highly likely to be malignant
33
  but not often associated with  high histologic 
grade.
34
  The correlation between mammographic features and histologic grade was 
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evident in a study by De Nunzio et al when investigating 212 patients with invasive cancer 
which found that lesions presenting as stellate had significant correlation with low 
histologic grade, which suggests stellate as a good prognostic features and associated with 
reduced breast cancer mortality.
34
 This was supported later by  findings from Alexander et 
al, where patients with this type of lesion had better survival rate (more than 95%) as 
compared to other mammographic features.
33
 Unlike stellate, cancer characterized with 
NSD was associated with high histologic grade and larger size (up to 90milimeter).
34
 As 
high grade cancer is faster growing compared to low grade cancer, this may give a shorter 
window for this type of cancer to be detected.  Such factors may have been taken into 
account by the radiologists in their decisions at strict recall conditions, as they may 
improve the survival rate of the screened women. Conversely, other lesions such as 
calcifications, mixed features and NSD have high likelihood of being  benign lesions, 
35
 
thus perhaps justifying the reduced need to recall these lesions.  
This study was conducted in a laboratory environment rather than a clinical setting 
which may have affected the readers‟ reporting pattern. A previous comparison study by 
Gur et al 
36
 with nine experienced radiologists demonstrated higher recall rates when the 
reading took place in the laboratory as compared to in-clinic reading. On the other hand, in 
our study radiologists were “forced” to recall the most significant cases that required 
further assessments and were not allowed to exceed a prescribed recall rate. In some cases, 
although the radiologists found more cases might need to be recalled, they had to in effect 
„let go‟ some of the cases due to the strict recall rule. In addition, it may be argued that a 
relatively low number of each cancer type was presented in this study. However, we 
believe that it has given important insights of the type of breast cancer that affect upon 
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reader‟s recall decisions. A study with a greater number of cancer types and readers will 
minimize biasing in results.  
Conclusion  
This study provides important insights into the types of cancer cases that contribute to the 
greatest uncertainty or are missed at low recall rates. Cancers with a stellate mass were 
more easily detected and are likely to continue to be recalled, even at lower recall rates.  
Lesions with non-specific density and mixed features were most likely to be recalled at 
reduced recall rates. By understanding which cancer features are likely to be missed, a 
dedicated training intervention can be developed to improve readers‟ performance when 
considering an optimal recall rate. 
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CHAPTER 7 
DISCUSSION AND CONCLUSION
 155 
Background 
Mammography reporting is challenging due to the heterogeneity of the breast parenchyma 
and subtlety of breast lesions. Some lesions may be difficult to categorize and patients 
having such lesions are often recalled for additional examination(s). However, the majority 
of the recalled cases tend to be benign or negative (1). To reduce unnecessary recalls, costs 
and patient stress associated with additional imaging, different countries and screening 
programs have guidelines for recalling clients and have set recall rates recommendations 
(2-6).  
The literature review (Chapter 2) explored the multiple factors that affect the recall 
rates results of screening mammography. Large variations in the recall policies are evident 
within screening mammography programs across different countries (1, 7). Differing 
methods of screening (imaging technologies), the characteristics of the screened 
population, practices among radiologists or breast readers and health policies in the 
respective countries are all suggested as confounding factors responsible for the variability 
in the reported recall rates in prior studies (8). Furthermore, there is a paucity of 
information on how varying recall rates affect the performance of radiologists and their 
decision to recall abnormal cases in screening mammography. This paucity of evidence 
warrants further investigation. Therefore, this thesis explored the impact of setting 
different target recall rates on the performance of breast radiologists (Chapter 5). It also 
assessed the mammographic characteristics of breast lesions that influenced breast 
radiologists‟ decision to recall (in Chapter 6). This chapter (Chapter 7) integrates and 
analyses the outcomes of the two studies conducted. 
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The outcome of this work is also compared to published literature on this subject 
and the implications of recall rate recommendations upon the performance of breast 
radiologists in breast cancer detection are discussed.  Secondly, the findings of the types 
and mammographic characteristics of cancers that are more or less likely to be recalled are 
summarized and discussed. Finally, the clinical implications of these findings to clinicians 
and policy-makers are also considered. The limitations of the thesis and recommendations 
for future studies are suggested. 
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Discussion of Study 1: To investigate the effect of reduced recall rates on breast 
radiologists’ performance using receiver operating characteristic (ROC) and Jacknife 
free response operating characteristic (JAFROC) analysis.  
False positive findings have psychological consequences for clients, such as 
anxiety, and increase the cost of breast screening programs (9-13). It is expected that by 
limiting the number of recalled cases in screening programs, the number of false positive 
outcomes are reduced. Data produced from this thesis shows that the false positive rate of 
breast radiologists was significantly reduced by 3-9% when recall rates were lowered. On 
the other hand, specificity increased at lower recall rates (0.95 at 10% and 0.92 at 15%). 
This was achieved at the expense of lower sensitivity. The sensitivity decreased 
substantially from an average of 0.80 at free recall to 0.65 at 15% recall and 0.55 at 10%. 
Sensitivity was higher at free recall compared to 15% (0.80 vs 0.65). In other words, breast 
radiologists were able to detect more cancer lesions when they were allowed to work at 
free recall (or without a set recall rate target). 
Target recall rates have the potential to impact upon breast radiologists‟ behaviour. 
In order not to exceed the target recall rate stipulated in the guidelines, breast radiologists 
may need to adopt a stricter reporting criterion. Breast radiologists may choose to overlook 
lesions they consider less suspicious whilst recalling those they perceive to be more 
indicative of cancer. As reported by Carney et al in their study when analysing the impact 
of a web-based educational program upon the performance of community US radiologists 
with higher recall rates, 72.3% of participating radiologists would change their routine 
clinical behaviour in order to meet their recall rates and they did this by re-reviewing cases 
that had a smaller likelihood of being cancer (14).  
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Some breast radiologists take into account a woman‟s risk of breast cancer such as 
breast density, age, presentation of symptoms, the use of HRT prior to the time of 
screening, family history or previous biopsy history in their decision making process. 
However, these details were not provided to the participants in this laboratory study, so it 
is difficult to assess the impact of such information on their recall decision and we 
therefore need to conclude that the decisions made by our breast radiologists were made 
exclusively based on the mammographic images (appearances or characteristics of breast 
lesion).  
Mammographic characteristics such as dense tissue and the subtlety of breast 
lesions have been demonstrated to impact on breast radiologists‟ perception and contribute 
to missed cancers (15, 16). Even when lesions are visible, the analysis of the lesion 
depends on the impression created in the mind of the radiologist (17) which is very 
subjective. Another challenge in the interpretation task is if the lesion is rarely perceived 
by the radiologists. A visual search study by Wolfe et al found that lesions that occur less 
frequently in a screening scenario affected lesion detection and led to low performance 
(18). Thus lesion identification and detection by radiologists may be influenced by such 
internal variables (visual perception, subjectivity of human readers) which may be 
responsible for the differences in their decision at prescribed target recall rates. 
It should be noted that decision making for further assessment in mammography 
incorporates the interaction between visual perception and clinical judgement, both of 
which can be influenced by such factors as training and experience. Each breast radiologist 
employs different approaches in gathering and using information when making a decision 
to recall (19). It has been shown in a previous study that breast radiologists relied on their 
previous knowledge and experience when they perceived the presence of a lesion and 
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decided upon its cancer characteristics (20). In a study by Nodine et al, experienced breast 
radiologists generally demonstrated a higher performance than inexperienced residents 
when reading mammograms (20). This is because the decision-making process by 
experienced breast radiologists is based on their prior information from previous training 
and experiences, which is known as the memory-cueing hypothesis. Thus experienced 
breast radiologists search their memory for cues to recognize abnormalities that assist them 
in making a decision (21). In contrast, resident doctors and junior radiologists with limited 
experience tend to engage in  heuristic decision-making (21).  
Due to having a very homogenous group of readers in this study (with mean 
experience of 17 years and mean of 11,900 mammogram readings per year), the impact of 
these characteristics on performance at various recall rates in this thesis has not been 
evaluated statistically. Nevertheless, the readers did work in different practice settings and 
may have learned their skills under different mentorship conditions. Rothschild et al (2013) 
found practice site/location can significantly affect a radiologist‟s recall rate in screening 
mammography in the US, as recall rates were higher for radiologists practising in hospitals 
than community-based screening (22). Cumulative clinical knowledge acquired from 
various training and mentorships does make a difference in clinical decision making and 
thus may lead to variability in breast radiologists‟ decisions. This can be confirmed by the 
findings from this thesis that showed individual recall rates that ranged from 18.5% to 
34.0% when reading at the free recall condition. Therefore, it is logical that this variation 
in recall rates in the current study may be due to the breast radiologists acting according to 
their own individual practices and expertise.  
It is also worth noting that some breast radiologists are more risk averse than 
others. The differences in risk aversion may have been responsible for inter-reader 
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differences in decisions to recall in this work. All readers were aware of the laboratory 
nature of the study however real clinical decision making is more challenging when there 
is potential for litigation and medical diagnostic errors such as missed cancer. This may 
explain why the recall rates in the United States (US) are higher (currently around 15% of 
women are recalled) than breast screening in Australia and other national breast screening 
programs (23), as there is a documented history of litigation (24). For this reason, a breast 
radiologist may feel subtle pressure to recall a mammographic case instead of making a 
return to screening decision alongside the knowledge that a missed cancer due to error is 
likely to have a significant implication on patient‟s survival. Previous studies demonstrated 
that such errors have direct impact on physicians emotionally (25, 26). Therefore, 
heightened concerns about missing a cancer may be a key reason why the radiologists 
recall more cases for further assessment. 
Another interesting aspect found in this study is the individual recall rates 
demonstrated were higher than recommended by Australian clinical practice (10%), 
ranging from 18.5% to 34.0%. However, when the recall rates were reduced to 15% and 
10%, a substantial decrease in sensitivity was observed. A possible explanation for this 
was that the breast radiologists were aware the reading task was being performed in the 
laboratory setting where there were no effects on patient care or cost associated with 
further assessments. A previous study by Gur and colleagues when assessing the 
performance of nine board-certified American radiologists has found that radiologists have 
lower sensitivity when reading mammograms in the laboratory as opposed to in the clinic 
(0.89 vs 0.92 respectively) and recall more cases for further assessment (27). Furthermore, 
the radiologists may also presume the test set was enriched with abnormal cases as well as 
having the notion of being “tested” as individuals, perhaps resulting in biased responses 
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(28). Therefore, the radiologists may have altered their routine clinical behaviour and acted 
in a different manner from the way they would normally do in a clinic setting. 
The experimental set up for the reading environment in this study was designed to 
be as authentic as possible to the clinical setting in BreastScreen NSW. Although it is 
argued that the radiologist‟s behaviour in a laboratory setting might be different in the real 
clinical setting, a study by Soh et al (29) demonstrated  significant levels of reader 
agreement when reading the same mammographic cases in these two reading conditions: 
clinical and laboratory environment, with Kendall‟s coefficient of concordance (Kendall‟s 
W) varying from an acceptable to a good level (0.69 to 0.72), which supports the 
applicability of  the work in this thesis.  
When reading in the free recall condition, where the breast radiologists had an 
opportunity to recall more mammographic cases that they perceived as suspicious, a higher 
cancer detection rate was demonstrated. Hence the work from this thesis concurs with 
findings of a number of previous studies (23, 30, 31) demonstrating that higher recall rates 
improve the sensitivity of breast radiologists. However, free recall was associated with 
high false positive rates and this would likely hamper the effectiveness of a breast 
screening program. To ensure that a breast screening program is effective and successful, 
screening is not merely dependent on the number of cancers detected but also in reducing 
the number of unnecessary recall decisions among screened women, as false-positive 
recalls are associated with psychological consequences and an economic burden (9, 10, 32-
35). One must weigh the advantages of early detection against the disadvantages of false 
positive errors, and just as detection of more cancers may improve the survival rate and 
lower the mortality from breast cancer, a high false positive rate will reduce confidence, 
may lessen participation and likely be unsustainable financially to maintain.  
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Another interesting point to discuss is the possible effect on radiologists‟ reporting 
behaviours by the practice of double reading in BreastScreen Australia (BSA), which 
provides some context for the study. Although this is not part of this study, anecdotally, it 
was noted that this strategy may influence breast radiologists‟ behaviour in mammography 
screen reporting. Giving verbal feedback after the reading sessions in the current study, the 
participating breast radiologists spoke of their experience of being part of this double 
reading strategy context. In acknowledging the reading protocol in this study was set as a 
single reading, all our participating breast radiologists have worked in some capacity for 
BSA, where the double-reading strategy is applied. Of the five breast radiologists, the 
minimum number of years of working in breast screening was nine, therefore, it is possible 
that they may have been engrained into a double reading strategy/clinical work practice, 
and this may be difficult to diffuse. Knowing that in the clinical practice the 
mammographic images will be read by an additional blinded reader before or after them, 
the breast radiologists may have regarded the system of double reading as a safety net or 
buffer against error when they work clinically. Previous studies have demonstrated that 
breast radiologists with an established practice pattern have difficulty in changing their 
reporting behaviour (36, 37). 
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Discussion of Study 2: To assess which types of mammographic appearances of breast 
cancer are more likely to be missed when breast radiologists read at lower recall 
rates. 
The accuracy of radiological image reporting requires efficient search, perception 
and decision-making skills. Even when lesions are fixated and perceived, the 
categorization of such lesions as benign or malignant depends on their mammographic 
appearance (38-40). Whilst the features of some lesions can be more easily recognized, 
others present with features that are very subtle or non-specific (such as nonspecific 
density, NSD) for malignancy. Subtle mammographic features of breast lesions and NSD 
may create decision-making challenges for the breast radiologists and may be overlooked 
or dismissed at lower recall rates (41). The work in chapter 6 examined which types of 
mammographic appearances of breast cancer are most likely to be missed when breast 
radiologists read at lower recall rates. Findings of the work showed a significant reduction 
in sensitivity for cancer lesions presenting as non-specific density (P=0.04) and mixed 
features (P=0.01) at 15% recall rates but no difference in the detection of stellate lesions 
(P=0.18) and architectural distortion (AD) (P=1.00). Stellate lesions were also the most 
commonly recalled lesions by the breast radiologists, whilst the recall rates of lesions with 
mixed features (calcification+AD) and non-specific densities (NSD) were significantly 
reduced at 10% recall condition.  
According to Mello-Thoms et al (2006) the perception of a lesion depends on its 
visibility and background parenchymal changes (40). Stellate lesions have very typical 
features and create parenchymal changes that distinguish them from their background. 
They also have spiked linear extensions radiating outwards and spicules that can be easily 
recognized by radiologists (42). Therefore, the high sensitivity of the radiologist cohort for 
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this type of lesions in this work may be due to their conspicuity, typical mammographic 
appearance and associated parenchymal perturbations. Furthermore, according to the 
Breast Imaging Reporting and Data Systems (BI-RADS) classification scheme, stellate 
lesions are almost always malignant (43) and commonly present less than 1.5 cm in size 
(44). This type of lesion is often not associated with a high histologic grade in breast 
cancer (45) and is usually curable with early treatment.  
When Tabar and colleagues (2004) investigated the correlation of mammographic 
features of small invasive breast carcinomas (measuring 1-14mm) and long-term 
prognosis, they found that patients with stellate lesions had a survival rate more than 90% 
(46). A later study by Alexander et al (2006) investigating the  favourable outcomes of  
201 patients diagnosed with invasive breast cancer also demonstrated comparable findings 
(44), which suggests stellate lesions are a reliable indicator of good prognostic features 
(low histologic grade, high survival rate) in clinical decision-making. Therefore, our 
radiologists may have considered the clinical significance of the findings in their decisions 
to recall. This may explain the higher recall rates of the stellate lesion type of the current 
work.  
Conversely, lesions presenting with NSD demonstrated low sensitivity at the low 
recall rate (15% and 10%) conditions. Radiologists also demonstrated a low agreement in 
their decision to recall when lesions were associated with NSD (also called asymmetric 
density) (30). Although this lesion appearance sometimes precedes malignancy with a high 
histologic grade (31), an NSD is often regarded as benign rather than malignant (47). This 
may be due to the mammographic appearance of NSD that often mimics normal 
parenchymal heterogeneity with poorly defined characteristics of density (32). These 
NSDs are usually composed mostly of densities that are difficult to distinguish from 
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fibroglandular tissue in the breast. Unlike stellate lesions, the mammographic features of 
NSD often present as indirect and subtle signs of breast cancer. The indirect and subtle 
signs are those related to tissue reaction in the area of breast cancer (more than signs from 
the cancer itself) and often associated with other benign signs (48). Furthermore, the 
proportion of this type of lesion found in invasive breast cancer cases reported was very 
small as opposed to other mammographic features (44, 46, 49). This suggests the 
radiologists have relatively little exposure to cancers with this mammographic appearance.  
In a previous visual search study by Wolfe et al it was found that readers would 
change their decision criteria at low prevalence which led to miss error and lower 
performance (50). Thus when a target recall rate is set, features that mimic benign 
conditions and lack evidence of malignancy may have a high likelihood to be overlooked 
and dismissed. This can be either due to an uncommon cancer presentation or a variability 
in the knowledge of the radiologists (24, 33), even though the lesion is visible on a 
mammogram and perceived by some radiologists.  
The same reason may also explain the inconsistency in radiologists‟ decision 
making when detecting lesions characterized with AD as observed in this study. AD is 
often associated with many benign conditions such as radial scars, sclerosing adenosis, fat 
necrosis, previous surgery, trauma and infection, thus perhaps justifying the reduced need 
to recall these lesions (51-53). A 10% reduction in sensitivity was reported by van Breest 
and colleagues (2016) for women with a previous history of surgery mainly due to the 
scarring of breast parenchyma which mimics AD in mammograms (51). Even if AD is 
perceived, it is a difficult task for a radiologist to make a decision whether it is benign or 
malignant. A study by Suleiman et al demonstrated a significantly lower sensitivity and 
lower ROC AUC for AD lesions compared with the detection of other lesions types (52). 
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Due to this array of confounding conditions, AD may be easy to overlook and 
misinterpreted as being benign, with AD demonstrated to constitute to approximately 18% 
of missed cancers in a study reported by Burrell et al (53).  
It is also noteworthy that another perceptual factor such as mammographic breast 
density affects cancer detection in 2-dimensional mammography. Data from this thesis 
demonstrates that cancer lesions present in mammograms with higher mammographic 
breast density (BIRADS 3 and 4) were likely to be missed when reading at limited recall 
rates. Due to the similarity of mammographic appearance between fibroglandular tissues 
and breast lesions,  high mammographic density can obscure the breast lesions with subtle 
malignancy signs and increase the risk of interval cancer four times higher than breasts 
with low mammographic density (54). 
Findings from this thesis suggest the role of mammographic features of breast 
lesions are a predictor of breast radiologists‟ decision making in recalling for further 
assessment. Cancer with indirect and subtle signs of malignancy may challenge breast 
radiologists when making their decision to recall at low rates. In this study, NSD was the 
type of breast lesion that had the highest likelihood of being unrecalled and missed. 
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Implications of the findings this thesis 
Quality guidelines for breast cancer screening programs are intended to utilize data 
to improve quality outcomes and to help clinicians understand the gap between their own 
performance and national targets (2, 3, 55, 56). In this study, a significant reduction in the 
sensitivity of breast radiologists was evident when the target recall rates were reduced from 
free recall to 15% and 10%. It could be suggested as an implication from this thesis that 
reducing recall rates is associated with decreased performance in cancer detection. 
However, clinical decisions must be a balance of risk and benefit. Although a high recall 
rate may result in an increase in sensitivity as demonstrated at the free recall condition in 
this thesis, it also increases the number of FP results. Thus, this will raise great concern not 
only among the women attending screening (5, 13) but also with policy makers as this may 
in turn increase the cost associated with the additional radiological examinations. It has 
been reported that the high cost related to false positive decisions causes an enormous 
burden to services and individuals and it is estimated that more than USD $100 million per 
year is paid for false positive outcomes in the most populous state of the United States, 
California (57), however, no comparable figure was found for the Australian population. 
As a comparative figure, it was estimated that 24% of the health expenditure by the 
Australian Government was allocated to breast cancer, with AUD $118 million spent on 
screening mammography services through the BreastScreen Australia Program (58). 
Interestingly, an increment of 32% in breast cancer expenditure for women was reported in 
Australia from $252 in 2000-2001 to $331 for the 2004-2005 financial year (58) and 
largely this growth contributed to out-of-hospital medical expenses such as visits to general 
practitioners and specialists, as well as pathology and imaging services (58). 
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 Lowering recall rates in this study decreased the ability of breast radiologists to 
correctly detect cancer. The current work confirmed that benign-appearing soft tissue 
findings and indirect signs of malignancy such as non-specific density (NSD) had a higher 
probability not to be recalled at low recall rates as compared to other mammographic 
features. The detection of NSD lesions in mammograms is particularly important as this 
lesion is associated with high histologic grade cancer. Delaying in detecting such high 
malignancy cancer can decrease the survival rate of screened women.  
A strategy that has been established to assist in this regard is through educational 
feedback mechanism such as the BreastScreen Reader Assessment Strategy (BREAST) 
(59). BREAST provides opportunities for breast radiologists to assess a test bank of 
mammographic cases and feedback is provided at the end of the reading session that 
provides a learning/training platform for breast radiologists through self-directed 
educational activities (59). Through this mechanism, researchers and clinicians should now 
be looking at an improvement upon educational strategies that can use the current findings 
to help clinicians understand the nature and type of positive lesions that are likely for them 
to give away at a low recall rate. Thus, training interventions can be tailored and 
personalised to improve the diagnosis of breast cancer types that pose detection challenges. 
Conversely, a major challenge in breast screening is obtaining feedback on truth and the 
lesion type of a recalled disease, which is often unknown prior to biopsy and pathology 
correlation. Therefore, an educational feedback mechanism is essential for breast 
radiologists, particularly in Australia, where many people (both breast radiologists and 
clients) live remotely.  
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Another possible mechanism to improve breast radiologists‟ performance is by 
optimal pairing of breast radiologists in a double-reading environment. Although double 
reading in mammography is known to improve the efficacy of breast screening, there is 
little knowledge about how to optimise the process of pairing breast radiologists who 
complement each other in terms of skill mix. Currently in Australia, breast radiologists are 
randomly paired without considering the breast radiologists performance characteristics at 
an individual level. Both readers may or may not have a difficulty in recognizing and 
detecting some particular type of breast lesions. By pairing them randomly, there may be a 
possibility the breast radiologists will miss same breast lesions and this may hamper the 
efficacy of double reading strategy. By studying the characteristics and type of breast 
lesions that have low detectability and low recall rate for each reader based on evidence, 
optimal pairing may result in a greater number of malignant being detected and recalled for 
further assessment.  
Nevertheless, the experience of readers reading the mammographic images does 
change over time and this may challenge and limit the implementation of this strategy in 
the practice. This is because people may change their work behaviour, acquire knowledge 
or have changed knowledge as the results of their work practices. For example, if they 
have time away from reading mammograms for 6 months or more, this may limit their 
resources of working memory and affect their performance in reading mammographic 
images. Conversely, readers who are working through a large number of mammographic 
cases form a database of knowledge in their working memory that aids in decision-making. 
Another potential challenge that needs considering is the possibility all the radiologists 
who were employed in one service may not be able to be paired together due to some 
particular/logistical reasons and although the ideal is for radiologists to pair with someone 
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who complements their skill, this may not always be possible and the pairing strategy may 
be difficult to monitor consistently. 
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Strengths of the thesis   
In this laboratory-based reader performance study, an experiment was conducted in 
a controlled environment which allowed for minimization of the confounding factors such 
as viewing conditions and establishment of the effects of recall rates. The recall rate was 
treated as a primary indicator (independent variable) for assessing the performance of 
breast radiologists in screening mammography.  
Additionally, the work in this thesis has explored performance through a 
methodology that assesses the breast radiologists‟ ability to correctly locate lesions. The 
thesis answers an important question regarding whether setting a target recall rate affects 
behaviour of breast radiologists when interpreting a mammogram with regards to 
sensitivity, case sensitivity, lesion location sensitivity, specificity, receiver operating 
characteristic (ROC) area under the curve (AUC) and Jacknife free-response receiver 
operating characteristic (JAFROC) figure of merit (FOM). 
Data provided from JAFROC FOM analysis and lesion location from the work of 
this thesis is beneficial to clinicians as it does reflect actual behaviour of breast radiologists 
interpreting mammographic images. With greater statistical power over traditional 
methodologies reporting observer‟s performance, such as ROC (60, 61), the accuracy of 
breast radiologists to correctly identify each lesion on mammograms can be identified. 
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Limitations of the studies 
Some caution must be in place when interpreting data produced from this thesis due to the 
following limitations.  
Firstly, a relatively small number of readers (n=5) were used for the study. The 
reasonably large number of cases used in the test set (n=200) and the number of reads 
required for three reading sessions by each reader made it difficult to recruit a larger reader 
cohort. Although some breast radiologists initially showed their interest in participating, 
they could not commit to performing the repetitive reading task at the designed laboratory 
setting due to their tight clinical schedules. This limited the number of readers and this may 
have been a potential hindrance to explore more significant changes. 
Secondly, there were relatively small numbers of each lesion type in the sample. This 
may have minimized our ability to demonstrate the radiologists‟ performance at reduced 
recall rates for each lesion type, thus limiting generalizability of the results. Furthermore, 
the fact that the number of cases was chosen from a real population screening program 
audit makes it impossible to control and may lead to bias. However, the results provided 
from this thesis should inform further research activities. 
Thirdly, information on positive recall lesion type (true and false) cannot be 
provided at any stage of this study as it was not part of the study protocol; where the 
readers did not require to report the lesion type. This was done in order to keep as close 
with clinical practice where breast radiologists do not have to describe the lesion type they 
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wish to recall. Collection of this information in a future research project would be of great 
interest.  
 Fourthly, the test set was compromised of non-digital images (digitised images) and 
digital images. This may have potentially contributed to the variations in individual case 
image quality and hence may have affected radiologists‟ accuracy when reading the 
mammograms. However, this was done in order to keep as close with clinical practice 
where the radiologists cannot choose what type of mammographic images that they have to 
read. Some prior cases may be original film-screen images that have been digitised, 
however all cases passed the BreastScreen NSW image quality analysis. 
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Recommendation for future work 
Closely related to my project, these are some extensions that would help clarify my results:  
1. Larger sample size: A larger study with a diversity of reader experience and case 
load would allow clarification of the importance of experience when adhering to 
specific recall rates. It would be interesting to explore how readers with a range of 
experience adhere to different recall rates and also how varying recall rates would 
affect the readers‟ performance, and may yield some important relationships 
between lesion location sensitivity and experience.  
2. Availability of prior images: It would be of great interest to provide prior images 
(where available) on the mammographic cases within the test set and explore how 
this may affect breast radiologists‟ decision-making and performance in future 
work. This was a direct suggestion from the participating breast radiologists in the 
current work. Although prior images were deliberately omitted from the test set in 
order to simulate a first screening read, previous studies demonstrated that 
availability of prior images had an impact on breast radiologists‟ performance and 
assisted in their clinical decision making (62, 63). Thus, exploring such an effect 
will establish how the availability of prior images can impact breast radiologists‟ 
decision to recall, although this would result in an increase in reading time for each 
session, and may limit the interest of breast radiologists to participate in lengthy 
recall studies. 
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3. Visual search study: A study with eye-tracking analysis should also be employed 
in future work as this can offer an explanation for the findings and a more 
comprehensive understanding about how a lesion is missed and how the decisions 
are made. This is particularly important as the work in Chapter 6 of the thesis has 
demonstrated that detection rate for certain type of breast lesions (such as non-
specific density) are unlikely to be recalled when the recall rates decreases, 
however without eye tracking analysis, it cannot be known for certain if the breast 
radiologists fixated on the lesions or not. 
4. False positive recall decisions analysis: Further analysis should be done on data 
gathered for false positive decisions to identify the nature of the features that were 
marked for recall but were not cancer. The work in this thesis did not record the 
mammographic characteristics of false positive recalls. Information on the false 
positive recall rates, the false positive lesion type and whether the same false 
positive lesions were recalled by multiple readers may benefit clinicians when 
considering an optimal recall rate in screening mammography. Study of these false 
positive recall decisions may contribute to the body of knowledge as to why some 
normal mammographic images are difficult to interpret and hard to recognize. The 
outcome of this analysis may suggest ways to reduce the false positive recall rate 
and improve specificity in breast screening. 
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Conclusion  
Findings provided in this thesis suggest that reducing recall rates through 
recommended target recall rates may reduce the false positive (FP) rate in screening as the 
specificity increases; however, this could also have direct effect on the early detection of 
breast cancer as reduced recall rates may result in a corresponding reduction in cancer 
detection. Detection of some types of breast cancer may be delayed and survival outcomes 
decrease with a reduced recall rate. Further work from this thesis also demonstrates the 
appearances of subtle and indirect signs of malignancy such as non-specific density (NSD) 
appear to be strongly related to reducing detection of cancer at low recall rates. While 
cancer with obvious and direct signs of malignancy such as stellate masses has a higher 
detectability regardless any recall rates. The evidence produced in this thesis provides 
insights about how to improve the performance of radiologists in breast screening 
mammography through appreciating the multifactorial nature of screening. Hence, this 
may inform the future work in designing key educational strategies towards optimizing 
diagnostic efficacy. 
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Appendix N: Performance metrics  
Performance 
metrics  
 
Description  
Sensitivity  Measures the percentage or fraction of actual positive cancer cases that are correctly 
identified by the reader.  Often described as a decimal. Mathematically can be expressed 
as  
 
            
                            
                                               
 
   
            
  
     
 
 
Specificity  Measures the percentage of fraction of cancer free cases that are correctly identified by 
the reader. Often described as a decimal. Mathematically can be expressed as  
 
            
                            
                                                          
 
            
  
     
 
 
Receiver 
operating 
characteristic 
(ROC) 
analysis 
 
ROC analysis is a binary paradigm focused on a single rating per case. the 
patient either does or does not have disease, i.e., truth is binary. The radiologist‟s task is 
to state whether the patient does or does not have disease, i.e., the response is binary. 
The resulting 2 x 2 truth-response table defines good decisions (true positives (TP), true 
negatives (TN)) and bad decisions (false positives (FP) and false negatives (FN)). The 
performance measure rewards good decisions and penalizes bad decisions.   
In this study, a TP score was given to a case when the reader correctly identified 
the correct side of the breast containing cancer, without the need to show the specific 
location of the lesion. This analysis is based on the ROC equivalent ratings inferred 
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from the free-response data; where the rating of the highest-rated mark is included for 
comparison as it is the current gold standard. The ROC figure of merit is the area under 
the ROC curve (AUC). Radiologists will be asked to rate each case for probability of 
disease. The truth is known to the person running the study but not the radiologists. 
DBM-MRMC software is available on two websites that analyze MRMC-ROC data, and 
if the p-value is less than 5% one concludes that there is a statistically significant 
performance difference between at least two modalities.   
                             
                  
                               
 
                             
                  
                               
 
                               
                  
                            
 
                              
            
                              
 
Therefore;  
          and           
The ROC curve is the plot of TPF along the y-axis vs. FPF as the confidence level is 
varied. The ROC curve is contained within the unit square. AUC = area under the ROC 
curve and 0 ≤ AUC ≤ 1. AUC is the probability that an abnormal image is rated higher 
than a normal image.  
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Jack-knife 
free-response 
ROC 
(JAFROC) 
analysis 
 
JAFROC analysis is an advanced quantitative analysis of reader performance 
when interpreting mammography images. This analysis incorporates a free-response 
paradigm that allows lesion location information to be included when analysing reader 
performance. The JAFROC figure-of-merit (FOM) is the non-parametric (Mann-
Whitney-Wilcoxon U-Statistic) area JAFROC under the AFROC curve and it is defined 
by  
 
Where;  
NN =     number of normal cases 
NL= total number of lesions 
Xi= the rating of the highest rated mark on the i
th 
normal case 
Y
j
= the rating of them j
th
 lesion. 
**unmarked normal cases and unmarked lesions are assigned the -2000 rating. 
Whereas the non-lesion localization marks on the abnormal cases are not be counted. 
 
 In this study, a TP score was given to a lesion when a reader successfully 
Figure 1 ROC graph
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marked and localized the lesion correctly within the acceptance radius. Furthermore, 
with the additional information of lesion location, this method demonstrates higher 
statistical power as compared to the ROC analysis. Through this method of analysis, the 
readers were allowed to locate multiple suspicious lesion locations during the 
interpretation process. The non-parametric area under the alternative free-response 
receiver operating characteristic (AFROC) curve was used as the figure of merit for 
JAFROC and the graph was plotted as the lesion localisation fraction (LLF) versus false 
positive fraction (FPF) or non- lesion localization (NLL). The software implementing 
JAFROC is available on www.devchakraboty.com.   
 
 
 
Figure 2 AFROC graph 
